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 i 
Résumé 
Les infiltrations foraminales cervicales sont associées à un risque de complications 
neurologiques majeures. Cette étude compare l’efficacité des infiltrations facettaires, plus 
sécuritaires, à celle des infiltrations foraminales dans le traitement de la cervico-brachialgie 
secondaire à une spondylose et/ou à une hernie discale, à 4 semaines post traitement. 
Cinquante-six sujets ont été randomisés pour recevoir une infiltration foraminale (15 
hommes, 13 femmes ; âge moyen 52 ans) ou facettaire (8 hommes, 20 femmes ; âge moyen 44 
ans). L’issue principale était l’intensité de la douleur mesurée sur une échelle visuelle 
analogique (0 – 100). Les issues secondaires étaient le Neck Disability Index et le Medication 
Quantitative Scale.  
Suivant les analyses en intention-de-traiter et en intention-du-protocole, pour un score 
de douleur initial moyen, une réduction significative de l’intensité de la douleur a été observée 
avec les infiltrations facettaires [45.3% (95%CI: 21.4; 69.2) et 37.0% (95%CI: 9.2; 64.7)] 
contrairement aux infiltrations foraminales [9.8% (95%CI: +11.5; 31.2) et 17.8% (95%CI: 
+6.6; 42.2)]. Les infiltrations facettaires ont procuré une amélioration cliniquement (mais non 
statistiquement) significative du Neck Disability Index [24.3% (95%CI: +2.9; 51.5) et 20.7% 
(95%CI: +6.2; 47.6),], contrairement aux infiltrations foraminales [9.6% (95%CI: +15.2; 34.4) 
et 12.8% (95%CI: +11.2; 36.7)]. Les infiltrations facettaires étaient au moins aussi efficaces 
que les infiltrations foraminales pour un score initial de douleur ≤ 60, alors que l’analyse de 
non infériorité n’était pas concluante pour un score initial ≥ 80, de même que pour le Neck 
Disability Index. Les infiltrations n’ont pas été associées à une réduction du score de 
Medication Quantitative Scale. 
Les infiltrations facettaires sont efficaces dans le traitement de la névralgie cervico-
brachiale et représentent une alternative valable et plus sécuritaire aux infiltrations 
foraminales. 
 
Mots-clés : Cervico-brachialgie, rachis cervical, hernie discale, spondylose, intervention 
spinale, infiltrations facettaires, infiltrations foraminales, traitement de la douleur. 
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Abstract 
Transforaminal corticosteroid injections can be performed in the management of 
cervical radiculopathy but carry the risk of catastrophic complications. This study compares 
the efficacy of transforaminal and facet corticosteroid injections at 4 weeks post treatment. 
We randomly assigned 56 subjects to receive CT-guided transforaminal (15 men, 13 
women; mean age 52 years; range 28 – 72 years) or facet (8 men, 20 women; mean 44 years; 
range 26 – 60 years) injections. The primary outcome was pain severity rated on a visual 
analog scale (0-100). Secondary outcome measures were the Neck Disability Index and the 
Medication Quantitative Scale.  
In the intention-to-treat and as-treated analyses, for a mean baseline score, facet 
injections demonstrated a significant pain score reduction of 45.3% (95%CI: 21.4; 69.2) and 
37.0% (95%CI: 9.2; 64.7), while transforaminal injections showed nonsignificant pain score 
reduction of 9.8% (95%CI: +11.5; 31.2) and 17.8% (95%CI: +6.6; 42.2). While facet 
injections demonstrated an improvement in Neck Disability Index score of [24.3% (95%CI: 
+2.9; 51.5); 20.7% (95%CI: +6.2; 47.6),] as opposed to transforaminal injections [9.6% 
(95%CI: +15.2; 34.4); 12.8% (95%CI: +11.2; 36.7)], the results did not reach statistical 
significance. Noninferiority of facet to transforaminal injections was demonstrated for 
baseline pain score ≤ 60, while noninferiority analysis was inconclusive for baseline pain 
score ≥ 80 and for the Neck Disability Index score. Neither intervention showed a significant 
medication intake score reduction over time. 
Facet injections are effective for the treatment of cervical radiculopathy and represent a 
valid and safer alternative to transforaminal injections.  
 
Keywords: Cervical spine, cervical radiculopathy, cervical disc herniation, cervical 
spondylosis, cervical foraminal stenosis, spine injections, transforaminal steroid injections, 
intra-articular facet steroid injections, spine intervention, pain management. 
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Introduction 
Cervical radiculopathy is a debilitating condition that affects approximately one person 
per 1 000 of population per year. Most patients will respond favorably to medical treatment, 
which may include rest, the use of analgesics and/or nonsteroidal anti-inflammatory drugs 
(NSAIDs), physical therapy and corticosteroid injections. Surgery is indicated when red flags 
such as, signs of myelopathy and deleterious sensory or motor impairment have been 
identified, or when medical treatment has failed. The prognosis following medical or surgical 
treatment is generally good to excellent. Although debilitating, cervical radiculopathy is not a 
life-threatening condition. Therefore, the expected benefits of our therapeutic interventions 
should outweigh significantly the risk of complications. 
In recent years, catastrophic neurological complications following transforaminal 
steroid injections (TFSI) have been reported. TFSI are used to treat cervical radiculopathy on 
the basis of several non-controlled observational studies, which have reported encouraging 
results, but their efficacy has yet to be demonstrated in randomized controlled trials. As 
musculoskeletal radiologists who perform spinal interventions, we were faced with a dilemma: 
Should we continue performing TFSI in view of the potential risk of serious neurological 
complications?  
Preliminary work by Kim et al. in 2005, had suggested that intra-articular facet steroid 
injections could be effective in patients with cervical disc herniations1. Anatomically, the facet 
joint ventral recess is in close proximity to the spinal nerve root. Therefore, using a facet joint 
injection approach to deliver corticosteroids in the vicinity of the injured spinal nerve root 
seem to be a viable alternative to the riskier transforaminal approach.  
These considerations prompted me to design a study to test the hypothesis that intra-
articular facet steroid injections (IFSI) would be at least as effective as TFSI at treating 
cervical radiculopathy. My objective was to design a randomized controlled study that would 
yield good-quality data that could impact on the clinical management of patients with cervical 
radiculopathy. 
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With the help of my co-investigators, I submitted a grant application to the Fonds de 
recherche du Québec – Santé and I was awarded, as principal investigator, a $50,000 grant 
(FRQ-S, grant # 21230-2; 2010-2013) to conduct this study. Later on, I was also awarded an 
$8,000 grant from the Fonds Académique du Département de Radiologie, Radio-oncologie et 
Médecine nucléaire de l’Université de Montréal (2012 – 2013) to complete the research 
project. From the conception and design of the study, to the drafting of the manuscript, and the 
submission of the final manuscript to the American Journal of Neuroradiology (AJNR), I was 
responsible for the coordination of the entire research project and I take responsibility for the 
integrity of the work as a whole. 
The Research Ethics Committee of the Centre hospitalier de l’Université de Montréal 
approved our study (Appendix I) and all participants received written and verbal information 
and gave their written consent (Appendix II).  The documents pertaining to the Eligibility 
criteria, Exclusion criteria, Neck Disability Index questionnaire and Visual Analog Scale that 
were used in the study are presented in the Appendices III to VI respectively. 
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Chapter 1. Cervical radiculopathy  
1.1. Epidemiology 
Cervical radiculopathy refers to a group of symptoms and signs caused by the 
dysfunction of a cervical nerve root. It typically presents with neck pain radiating to the upper 
limb with a combination of sensory disorder, altered reflexes or motor weakness in the 
anatomical distribution of the affected spinal nerve 2. In the population-based retrospective 
cohort study from Rochester, Minnesota (MN), from 1976 to 1990, the annual age-adjusted 
incidence of cervical radiculopathy was approximately 1 in 1000 people, with a male to 
female ratio of 1.7 3. The peak incidence was at 50 to 54 years of age with an average 
incidence of 203 per 100,000 people. In 1996, the authors of another epidemiological study on 
cervical radiculopathy conducted in a Sicilian municipality reported a prevalence of 3.5 cases 
per 1000 people 4. In both of these studies, the incidence of cervical radiculopathy decreased 
significantly after the age of 60 years 3, 4.  
In Radhakrishnan’s study, irritation of the nerve roots was caused by cervical 
spondylosis, a disc herniation or both in 68% of the cases, and by a disc herniation in 22% of 
the cases. Only 15 % of the patients reported a history of trauma or physical exertion 
preceding the onset of symptoms. The most frequently involved nerve root was C7 in 46% of 
the cases, followed by the C6 nerve root in 18% of the cases and by the combined involvement 
of the C5 and C6 nerve roots in 10% 3. 
Data on the natural history of cervical radiculopathy are still relatively scarce 5-8. 
According to the data from Rochester, MN, during the median duration of follow-up of 4.9 
years, recurrence of cervical radiculopathy occurred in 31.7% of the cases and 26% of the 
patients underwent surgery 3. Long-term prognosis in patients treated either conservatively 
(analgesics, anti-inflammatory drugs, physical therapy) or with surgery, is equally good with 
improvement in pain, neurological symptoms and functional status, although pain relief occurs 
more rapidly in patients treated with surgery 6.  
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1.2. Anatomy 
The cervical spinal nerves are constituted by the reunion of the ventral and dorsal nerve 
roots that emerge from the spinal cord (Figure 1). As it progresses through the intervertebral 
foramen, the dorsal nerve root enlarges to form the spinal ganglion proximal to joining the 
ventral nerve root to form the spinal nerve. The spinal nerve exits the spinal canal through the 
intervertebral foramen above the vertebra, which bares the same number. Hence, the C7 spinal 
nerve exits through the C6-C7 foramen and the C8 nerve exits through the C7-T1 foramen 
(Figure 2). 
 
 
 
Figure 1. Spinal cord and nerves.  
3D illustration of the spinal cord demonstrates the dorsal nerve root (curved arrow) that 
enlarges to form the spinal ganglion (thick arrow) before joining the ventral nerve root (long 
arrow) to form the spinal nerve. www.Anatomy.TV by Primal Pictures. 
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Figure 2. Cervical spinal nerves.  
Coronal 3D illustration of the cervical spine shows the dorsal ganglions (yellow segments) and 
spinal nerves (pink segments) passing obliquely infero-laterally to their exit through the 
intervertebral foramina. www.Anatomy.TV by Primal Pictures. 
 
 
The intervertebral foramen has an anterolateral orientation relative to the coronal plane. 
It is bounded superiorly and inferiorly by the pedicles of the adjacent vertebrae. The 
posterolateral aspect of the uncovertebral joint forms the anterior wall of the foramen, while 
the facet joint forms its posterior wall. The lateral margin of the foramen is demarcated by a 
line joining the anterolateral vertebral body and the lateral aspect of the facet joint. The 
vertebral artery (VA), which originates from the subclavian or innominate artery, runs in a 
caudad-to-cephalad direction immediately in front of the external opening of the intervertebral 
foramen and enters, in most cases, the foramina transversaria at C6 9. 
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Figure 3. Intervertebral foramen.  
Axial CT image (A) and corresponding illustration (B) of a cervical vertebra demonstrate the 
intervertebral foramen (star), bordered anteriorly by the uncinate process (long arrows) and 
posteriorly by the facet joint (curved arrows). The illustration (B) also shows the ventral and 
dorsal nerve roots emerging from the spinal cord and coursing through the intervertebral 
foramen. The vertebral arteries (thick arrows) are seen within the foramina transversaria, in 
front of the external opening of the intervertebral foramina. www.Anatomy.TV by Primal 
Pictures. 
 
         
The nerve root is enclosed within its dural sleeve and runs within the lower half of the 
foramen while the epiradicular veins occupy the superior half. The spinal arterial branches 
originate from the vertebral, the ascending cervical, the deep cervical or the superior 
intercostal arteries 10. These spinal arterial branches traverse the intervertebral foramen 
alongside the spinal nerves and continue as radicular arteries, which in turn will join the 
anterior and posterior spinal arteries to supply the spinal cord 11. The majority of these vessels 
traversing the intervertebral foramen occur in the lower levels of the cervical spine. Although 
the radicular arteries are most commonly located inferiorly and anteriorly to the spinal nerve 
roots, a wide anatomic variation in the origin and location of these vessels exists. Hence, it has 
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been demonstrated that branches from the ascending and deep cervical arteries course within 
the posterior aspect of the intervertebral foramen and occasionally participate to the anterior 
and posterior vascular supply to the spinal cord 12.  
 
 
  
Figure 4. Vascular supply to the cervical spinal cord.  
Coronal illustration (A) of the cervical spine depicts the vertebral arteries (long arrows), deep 
cervical arteries (curved arrows) and ascending arteries (shown in green color) coursing in a 
caudad-to-cephalad direction. These arteries have several branches including the spinal 
arteries, which run through the intervertebral foramina alongside the spinal nerve roots, as 
shown on the 3D illustration of the spinal cord (B), to join the anterior and posterior spinal 
arteries that supply the spinal cord. www.Anatomy.TV by Primal Pictures. 
 9 
The cervical facet joint (also called zygapophyseal joint) forms the posterior limit of 
the intervertebral foramen. It is a diarthrodial joint formed by the articulation of the inferior 
articular process (facet) of the superior vertebra and the superior articular process (facet) of the 
inferior vertebra at each spinal level. The articular processes arise from the lateral mass of the 
vertebra at the confluence between the lamina and the pedicle. A fibrous capsule, lined by a 
synovial membrane, surrounds the joint and the articular surfaces are covered by hyaline 
cartilage. From C3-C4 through C8-T1, the facet joints are innervated by the medial branches 
of the dorsal rami of the spinal nerves above and below the joint 13.  
 
 
 
 
 
Figure 5. Anatomy of the facet joint.  
 3D illustration of a cervical vertebra (A) demonstrates the articular facets (long arrows). 3D 
illustration of the cervical spine (oblique view) (B) shows the facet joint space (curved arrow). 
Note that the facet joints form the posterior limit of the intervertebral foramina (stars) where 
the spinal nerves exit. www.Anatomy.TV by Primal Pictures. 
 
 10 
The facet joint can communicate with the interlaminar region, interspinous region and 
contralateral facet joint via an extradural space located dorsal to the ligamentum flavum. As 
cited by Murthy et al. 14, this potential space is called the retrodural space of Okada after the 
physician who described it in 1981 15. This potential space can be a pathway for the 
dissemination of contrast agent, corticosteroids, infection and tumor. 
  
 
Figure 6. Retrodural space of Okada.  
3D illustration of a cervical vertebra demonstrates the facet joint capsule (stars) in continuity 
with a potential anatomical space (long arrow) located between the ligamenta flava (grey 
linear band) anteriorly and the spinous process posteriorly. www.Anatomy.TV by Primal 
Pictures. 
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1.3. Physiopathology 
In the vast majority of cases, cervical radiculopathy is the result of degenerative 
cervical spondylosis, a disc herniation or a combination of both. Other causes such as 
infection, tumor or trauma are infrequent. Cervical spondylosis occurs from degenerative disc 
disease, which starts with the dessication of the nucleus pulposus. With age, the nucleus 
pulposus loses water, proteins and mucopolysaccharides and consequently, becomes smaller 
and stiffer. As the annulus fibrosus assumes more of the weight bearing charge, radial and 
concentric tears develop leading to subsequent disc bulging and loss of disc height 16 (Figure 
7).  
 
 
Figure 7. Degenerative cervical spondylosis. 
(A) Lateral view radiograph of the cervical spine shows degenerative disc disease at the C5-
C6 level characterized by loss of intervertebral disc height and anterior marginal osteophytes 
(long arrow). (B) Oblique view radiograph depicts marginal osteophytes arising from the 
uncinate processes (curved arrow) and protruding into the right C5-C6 neural foramen. 
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Loss of disc height occurs preferentially on the ventral aspect of the disc, at least initially. 
Segmental instability ensures which in turn leads to the development of osteophytes at the 
anterior margin of the vertebral body. As the intervertebral space decreases, the height of the 
neural foramina also diminishes causing stenosis. With altered biomechanics, degenerative 
changes also occur at the uncovertebral joints and the facet joints, with joint space narrowing 
and osteophyte formations, which protrude into the neural foramina compromising the 
diameter of the foramen and encroaching upon the nerve root ganglion. 
Disc herniations, which result from nucleus pulposus material protruding through a 
radial tear and beyond the margin of the disc may occur alone or be part of the degenerative 
changes of cervical spondylosis (Figure 8). 
 
 
Figure 8. Magnetic resonance imaging of a cervical disc herniation. 
(A) Sagittal view of the cervical spine demonstrates herniated disc material protruding into the 
spinal canal (long arrow) at the C5-C6 level. (B) Corresponding axial view shows the disc 
herniation (short arrow) indenting the spinal cord.  
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Both degenerative discs and herniated disc material can produce mediators of inflammation 
such as matrix metalloproteinases, nitric acid, interleukin-6 and prostaglandin E2 17. These 
biochemical agents play an integral role in tissue degradation and inflammation. 
Ultimately, two major mechanisms can potentially cause irritation to the nerve root: (1) 
nucleus pulposus material secondary to a disc herniation leaking onto the nerve root and (2) 
compression of the nerve by degenerative changes occurring at the intervertebral disc level, at 
the uncovertebral joints and/or at the facet joints. Furthermore, either of these 
pathophysiological mechanisms will induce 2 processes in the nerves: (1) an inflammatory 
reaction and, related to this (2) changes in ion-channel functioning thought to cause 
hyperexcitability and dysfunction of the nerve root ganglion responsible for radicular pain 18. 
  
1.4. Clinical symptoms and signs 
Cervical radicular pain should be distinguished from cervical radiculopathy, a disorder, 
which entails objective sensory disturbances, diminished or absent reflexes and motor 
dysfunction corresponding to the nerve root(s) involved. Patients may experience sharp pain, 
tingling or a burning sensation in the involved area. Two examination maneuvers that may 
help confirm involvement of a nerve root at the level of the foramen have been described 19. 
Shoulder abduction relief sign: the patient holds the arm over his or her head, typically 
resting the wrist or forearm onto the top of the head. A positive sign is relief of the radicular 
symptoms. Spurling’s sign:  while holding his or her neck in extension, the patient turns his 
head toward the affected side. A positive test exacerbates the radicular symptoms. 
In a large retrospective study of patients who had surgery for cervical radiculopathy, 
Henderson et al. reported the clinical presentation in 736 patients: 99.4% had arm pain, 85.2% 
had sensory deficits, 79.7% had neck pain, 71.2% had reflex deficits, 68% had motor deficits, 
52.5% had scapular pain, 17.8% had anterior chest pain, 9.7% had headaches, 5.9% had 
anterior chest and arm pain and 1.3% had left-sided chest and arm pain 20. Neurologic 
symptoms and signs corresponded with the affected disc level and nerve root, in 
approximately 80% of the patients. 
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Findings on physical examination vary depending on the intervertebral disc level and 
nerve root(s) that are involved. These findings, adapted from Carette et al. 2 and Rao et al. 21 
are summarized in Table I. 
 
Table I: Physical findings associated with cervical radiculopathy 
Disc 
level 
Root Pain Distribution Weakness Sensory Loss Reflex 
Loss 
C2-C3 C3 Suboccipital region, extending 
to the back of the ear 
_ _ _ 
C3-C4 C4 Neck and shoulder _ Neck and 
shoulder 
_ 
C4-C5 C5 Medial scapular border, lateral 
upper arm to elbow 
Deltoid, supraspinatus, 
infraspinatus 
Lateral upper 
arm 
Supinator 
reflex 
C5-C6 C6 Lateral forearm, thumb and 
index finger 
Biceps, brachioradialis, 
wrist extensors 
Thumb and 
index finger 
Biceps 
reflex 
C6-C7 C7 Medial scapula, posterior arm, 
dorsum of forearm, third finger 
Triceps, wrist flexors, 
finger extensors 
Posterior 
forearm, third 
finger 
Triceps 
reflex 
C7-T1 C8 Shoulder, ulnar side of 
forearm, fifth finger 
Thumb flexors, abductors, 
intrinsic hand muscles 
Fifth finger _ 
 
1.5. Differential diagnosis 
Other entities that may cause neck and arm pain including, intraspinal or extraspinal 
tumor, angina, reflex sympathetic dystrophy, infection, peripheral entrapment syndromes, 
thoracic outlet syndrome, brachial neuritis, rotator cuff and shoulder pathology, must be 
differentiated from cervical radiculopathy 16. Another common mimicker of cervical 
radiculopathy is cervical facet joint syndrome that may result from traumatic, inflammatory or 
degenerative processes 22. Studies have shown that each facet joint produces a distinct pattern 
of pain with a characteristic distribution 23-25. Hence, cervical facet syndrome may cause axial 
neck pain radiating to the occipital region, the posterolateral cervical region and the scapulo-
humeral region.  
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1.6. Imaging 
After clinical history and physical examination, radiographs of the cervical spine 
should be obtained in patients presenting with cervical radiculopathy. The study should 
include at least, anteroposterior and lateral views. In addition, lateral views in flexion and 
extension may be useful to assess the biomechanics of the cervical columns, while oblique 
views allow for assessment of the intervertebral foramina. Radiographs can show evidence of 
degenerative disc disease, uncovertebral and facet joints degenerative disease as well as 
foraminal stenosis resulting from bony degenerative changes (Figure 7).  
Magnetic resonance imaging (MRI) is the imaging modality of choice to investigate 
patients with cervical radiculopathy. Indications include the presence of symptoms and signs 
suggestive of associated myelopathy, infection, tumor or in view of progressive neurologic 
deficits. For most other patients, MRI should be limited to those who remain symptomatic 
after four to six weeks of conservative therapy which may include rest, NSAIDs and physical 
therapy 2. MRI should also be obtained before performing a corticosteroid injection to confirm 
the diagnosis, to correlate the lesion with the patient’s symptoms and to assess for any 
particular anatomic variant that could influence the performance of the procedure. It is also 
important to recognize that structural abnormalities, including disc herniations, disc bulging, 
central canal and foraminal stenosis may be asymptomatic and that these findings are 
commonly seen in older individuals 26. 
Although the contrast resolution of CT is limited compared to MRI, its spatial 
resolution is by far superior and it is very useful to characterize the extent of bony spurs, 
foraminal encroachment or the presence of calcified disc herniation or ossification of the 
posterior longitudinal ligament which may cause central canal stenosis (Figure 9). 
Furthermore, with the advent of the multidetector CT scans, the global resolution of the CT 
images has increased improving the diagnosis of disc herniation and disco-osteophytic 
complexes. 
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Figure 9. Combination of disc herniation and spondylosis. 
(A) CT scan axial image of a cervical vertebra demonstrates degenerative changes with bony 
proliferation at the uncinate process of the vertebral body (black arrow) but the disc herniation 
is more difficult to identify. (B) Conversely, the MR axial image in the same subject depicts 
the herniated disc material (white arrow) in a more comprehensive manner. 
 
 
1.7. Treatment 
Cervical radiculopathy resulting from cervical spondylosis and/or disc herniation is 
typically, initially managed by non-surgical measures unless the patient has detrimental 
extremity weakness, intractable pain, associated signs of myelopathy or when non-surgical 
measures have failed to result in symptoms reduction 27. Non-surgical management, often 
referred to as conservative or medical treatment, may consist of rest, use of a rigid collar, 
analgesics, NSAIDs, physical therapy and corticosteroid injections.  
In a study by Saal et al. 28, 26 patients with cervical radiculopathy secondary to a disc 
herniation were treated with a systematic conservative management approach. 20 (77%) 
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patients achieved an excellent or good recovery and 2 (1%) patients required subsequent 
surgery.  
In a randomized study of 81 patients with chronic cervical radiculopathy, Persson et al. 
6 demonstrated that surgery by an anterior approach, a customized physical therapy treatment 
or the use of a cervical collar were equally effective in the long-term (follow-up of 12 
months). At short-term (1 month of follow-up) the patients treated with surgery reported less 
pain and as the physical therapy group, better function.  
In a retrospective cohort study, Heckmann et al. 5 analyzed the functional outcomes of 
60 patients with cervical disc herniation with radiculopathy but without signs of cervical 
myelopathy. The 60 patients were prospectively assessed with an average follow-up time of 
5.5 years. 39 (65%) patients had been treated with conservative measures and 21 (35%) 
patients had undergone surgery (anterior approach). Patients in the surgical group initially 
presented with more severe and long-lasting neurological disturbances. In the group of 
patients treated conservatively, brachialgia improved in 100% and neurological disturbances, 
namely sensory disorders, reflex abnormalities and motor weakness improved in 97%, 59% 
and 94% respectively. In the surgical group, brachialgia improved in 97% of the patients and 
the neurological disturbances improved in 75%, 53% and 50% respectively. Residual 
intermittent neck pain was common in the conservatively treated group.  
The Cervical Spine Research Society Study was undertaken to assess the outcome of 
patients with recognized subacute or chronic cervical disorders referred to spine surgeons for 
evaluation and treatment 8. Forty-one spine surgeons participated in this multicentric study and 
patients were assessed at 1-year follow-up, by way of questionnaires that were reviewed by an 
independent blinded observer. Two-hundred-and-forty-six patients diagnosed with cervical 
radiculopathy were enrolled in the study. In 160 (65%) patients, medical treatment was 
recommended on the basis of the surgeon’s evaluation and in 86 (35%) surgery was 
recommended. Of the 246 patients, 155 (63%) returned for follow-up. Of these patients, 104 
(67%) received medical treatment and 51 (33%) underwent surgery. Both medically treated 
patients and surgically treated patients demonstrated significant improvement in overall pain 
and overall functional status.  
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These studies suggest that unless red flags have been identified, patients presenting 
with cervical radiculopathy should initially be treated with an optimized medical treatment 
management. In patients with subacute or chronic symptoms refractory to medical treatment, 
approximately 30% will be treated with surgery. In the appropriately selected patients, both 
medical management and surgery can treat cervical radiculopathy successfully. 
  
 
Chapter 2. Transforaminal steroid injections 
2.1. Efficacy 
The presumed therapeutic mechanism of corticosteroid injections is the suppression of 
the inflammatory cascade that is believed to be responsible for the symptoms and signs of 
cervical radiculopathy that result from a disc herniation and/or degenerative spondylosis. TFSI 
allow for delivering high concentration of corticosteroids directly and precisely at the site of 
the involved spinal nerve root. Many non-controlled, observational studies have evaluated the 
efficacy of TFSI for the treatment of cervical radiculopathy (Table II).  
Bush et al. treated 68 subjects for cervical radiculopathy with an average of 2.5 
injections and reported a complete resolution of symptoms at long term follow-up in 76% of 
the cases 29.  
In a retrospective study of 18 patients treated with one CT-guided TFSI, Berger et al. 
reported good or excellent results in 61% of their patients 30.  
Slipman et al. obtained good or excellent results in 60% of cases, at 12 to 45 months 
follow-up and an average of 2.2 injections, in a retrospective study of 20 patients suffering 
from a degenerative foraminal stenosis 31.  
Vallée et al. treated 32 patients with an average of 1.3 injections performed with 
fluoroscopy guidance, and obtained good or excellent results at 6 months in 53% of their 
patients 32.  
Similarly, Cyteval et al. obtained good or excellent results at one month, in 60% of 30 
patients, treated with one CT-guided TFSI 33.  
Finally, Lasbleiz et al. reported 45% efficacy using the Neck Disability Index (NDI) 
and 47% of efficacy using a visual pain scale at 3 months, in 34 patients treated with one CT-
guided injection 34.  
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Overall these results suggest that image-guided TFSI provide complete resolution of 
the radiculopathy in one third of patients, partial resolution of symptoms in another one third 
and are inefficacious in one third.  
More recently, Anderberg et al. randomized 40 patients presenting with chronic 
cervical radiculopathy (mean duration of symptoms of 31 months) from degenerative 
spondylosis, to receive one fluoroscopically-guided TFSI 35. The treatment group received an 
injection of mepivicaïne + methylprednisolone while the control group received an injection of 
mepivicaïne + saline. There was a positive response in only 30% of the patients in the 
treatment group at 3 weeks follow-up. There were no significant differences in treatment 
results between the two groups. 
 
Table II: Efficacy of transforaminal corticosteroid injections: non-controlled studies 
Author Study Approach Outcome 
measure 
Average 
number 
of 
injections 
Follow-up 
(average 
number of 
months) 
Results 
Bush 
1996 
Non-comparative 
prospective 
(n=68) 
 
 Verbal pain 
score 
2.5 39 76% excellent; 24% good 
Berger 
1999  
Retrospective 
(n=18) 
CT Verbal pain 
score 
1 15 61% better at short term; 
39% better at long term 
Slipman 
2000 
Retrospective 
(n=20) 
Fluoro Verbal pain 
score 
2.2 21 60% excellent or good; 
30% required surgery 
Vallée 
2001 
Non-comparative 
prospective  
(n= 32)  
Fluoro Visual pain 
score 
1.3 6 53% excellent or good; 
47% fair or poor 
Cyteval 
2004 
Non-comparative 
prospective 
(n=30) 
CT Visual pain 
score 
1 6 60% excellent or good; 
40% fair or poor 
Lasbleiz 
2008 
Non-comparative 
prospective 
(n=34) 
CT NDI; 
Visual pain 
score 
1 3 NDI 45% efficacy; 
Visual pain score 47% 
efficacy 
CT: computed tomography; Fluoro: fluoroscopy; NDI: Neck disability index 
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2.2. Technique 
Traditionnally, TFSI, for the treatment of cervical radiculopathy, have been performed 
with fluoroscopic 36-39, computed tomography (CT) 32, 33, 38 or a combined technique of CT-
fluoroscopy 40-42 guidance. More recently, some authors have advocated the use of ultrasound 
for real-time monitoring of these procedures 43.   
For a fluoroscopically guided injection, the patient is placed in the supine position with 
the head turned slightly opposite the side to be injected. The C-arm is angled obliquely 
approximately 45 degrees towards the side to be injected, as to obtain a well-defined view of 
the targeted foramen with the superior facet overlying the lamina (Figure 10). 
  
 
 Figure 10. Fluoroscopically guided transforaminal corticosteroid injection.  
(A) Oblique view radiograph shows the targeted point (thin arrow) at the posterior aspect of 
the intervertebral foramen. (B) Oblique view radiograph demonstrates the needle in place with 
contrast flowing in the posterior aspect of the foramen (curved arrow). (C) Anteroposterior 
view radiograph shows the spinal nerve root and exiting spinal nerve outlined by contrast 
(large arrow). 
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A needle is advanced in the plane of the xray beam, with intermittent fluoroscopic monitoring, 
until it contacts the superior facet at the level of the equator of the foramen. The needle is then 
redirected slightly anteriorly and advanced a few millimeters to penetrate into the posterior 
aspect of the foramen. Needle position is verified with a frontal view where the needle should 
project over the sagittal midline of the articular pillars. Injection of approximately 1 ml of 
nonionic contrast medium is then performed to confirm the adequate placement of the needle 
and the absence of intra-arterial injection. With optimal placement of the needle, the contrast 
should outline the exiting spinal nerve and the epidural space. 
To perform the procedure with CT guidance, the patient is placed in the supine position 
with the head turned approximately 45 degrees to the contralateral side from the injection. 
Axial images limited to the target cervical foramen are obtained from a topogram of the 
cervical spine and an appropriate entry site is chosen to avoid the carotid and vertebral arteries 
and the jugular vein, and to gain access to the posterior aspect of the foramen, in a plane 
parallel to the anterior surface of the superior facet of the facet joint. The needle is advance to 
the outer aspect of the foramen using intermittent CT fluoroscopy. Once the needle is in the 
desired position, approximately 0.5 to 1.0 ml of nonionic contrast agent is injected and 
controlled with CT fluoroscopy to exclude intra-arterial injection and confirm adequate 
distribution of the contrast (Figure 11). 
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Figure 11. CT guided transforaminal corticosteroid injection. 
(A) Axial CT image shows the path of the needle, which is parallel to the articular facet (long 
arrow). The needle tip is located within the posterior aspect of the neural foramen and 
posterior to the spinal nerve root. (B) Axial CT image demonstrates the distribution of contrast 
within the neural foramen (black arrow) and extending to the posterior epidural space (curved 
arrow) within the spinal canal. V = vertebral artery; C = Carotid artery; J = Jugular vein. 
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2.3. Potential complications 
Steroid injections for the treatment of cervical radiculopathy occasionally cause minor adverse 
immediate reactions such as: vasovagal reaction, increased pain at the site of injection, 
increased radicular pain, numbness or weakness of the arm, headache, dizziness, nausea, 
hypersensitivity reaction and transient global amnesia 44. In a large series of 1036 
fluoroscopically guided extraforaminal injections, Ma et al. 45 reported a prevalence of 1.6% 
(14 cases) of minor adverse effects. In the past 15 years, an alarming number of severe 
neurological adverse events has been reported in the literature, paralleling the rapid growth of 
interventional pain management procedures performed over the same period of time 46. 
Although a confirmed case of direct puncture of the spinal cord has been reported 47,  the 
mechanism causing other numerous serious complications is still debated. The true risks of 
severe complications associated with these procedures remain unknown since only relatively 
few cases are being published in the literature. Nevertheless, in view of these dramatic 
complications and the lack of randomized controlled trials establishing their real efficacy, 
some authors have raised doubt about the justification for performing TFSI 36, 48.  
In an effort to determine the prevalence of severe complications, Scanlon et al. 49 
performed an anonymous survey among the members of the American Spine Society. At the 
time of the study, the membership of the society was composed of anesthesiologists (76%), 
physiatrists (17%), orthopedic surgeons (3%) and radiologists (< 1%). Among 1340 members, 
the response rate was 21.4% (287). In all, 78 complications were reported including: 
 
• 16 vertebrobasilar brain infarcts (cerebellum, brainstem or posterior cerebral artery 
territory) 
• 12 cervical spinal cord infarcts 
• 2 combined brain / spinal cord infarcts 
• 13 deaths (5 with brain infarcts; 1 with combined brain / spinal infarct; 1 following 
high spinal anesthesia; 1 associated with seizure; 5 with unspecified etiology) 
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2.3.1. Vertebral artery injury 
Suresh et al. reported the case of a 60-year-old man who suffered a cerebellar and 
brainstem infarction following a CT-guided C4-C5 TFSI performed with a 25G needle 50. A 
magnetic resonance angiography was performed and did not reveal evidence of a VA 
dissection. The patient’s condition improved and he had a progressive recovery over the next 
month. The authors concluded that the most likely cause of this dramatic incident was a VA 
vasospasm secondary to unintended direct puncture of the VA. 
Wallace et al. reported the imaging findings of two cases of VA dissection following 
TFSI 51. Rozin et al. reported the autopsy findings in a 44-year-old woman who died following 
a C6-C7 TFSI 52. The cause of death was a brainstem and cerebellar ischemic infarct with 
massive cerebral edema, secondary to a dissection and subsequent thrombosis of the left 
vertebral artery (VA), caused by inadvertent perforation of the artery with a 25G spinal needle 
during the procedure. Reflecting on this case, and on another similar case reported by 
Beckman et al. 53, de-Leon-Casasola questioned the likelihood that a puncture with a 25G 
needle would cause a dissection of a normal VA 54. He suggested that these patients might 
already have had a small VA dissection that was aggravated by the 25G needle puncture. 
Considering the relative prevalence of VA dissection in the low cervical levels of patients with 
a history of neck manipulations or accelerating / decelerating injuries, and the wide anatomic 
variation of the VA at low cervical levels, recognizing this potential additional risk factor is 
important.  
2.3.2. Intravascular injections of corticosteroids 
Arterial injection of particulate steroids causing an embolic phenomenon is the most 
frequently cited presumptive cause of brain and spinal cord infarcts 55-59. While performing a 
TFSI, despite using careful and precise technique, it is possible to cause inadvertent injection 
of material into radicular arteries that feed the spinal column 60. Cadaveric studies have 
demonstrated the variability and complexity of the vasculature in the vicinity of the 
intervertebral foramen and the inconsistent presence of critical arteries in the posterior aspect 
of the foramen susceptible to needle cannulation in the course of a TFSI 12.  
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In a prospective study of 504 consecutive fluoroscopically guided TFSI, Furman et al. 
reported a 19.4% rate of fluoroscopically confirmed venous or arterial intravascular contrast 
injections using a 25G spinal needle 61. Remarkably, using the spontaneous return of blood in 
the needle hub or after attempted aspiration with a syringe, predicted an intravascular injection 
with 97% specificity but only 45.9% sensitivity. 
2.3.2.1. The role of the technique  
Although there is no consensus in the literature as to what constitutes the most 
effective and safe method of performing epidural steroid injections 39, 62, the necessity to use 
image guidance and contrast medium injection to achieve accurate needle placement has long 
been recognized 63.  
To minimize the risk of inadvertent intra-vascular injection, some authors have further 
recommended using live fluoroscopy or real time fluoroscopy with digital substraction 
angiography 60 to monitor contrast media injection more accurately and confirm the 
extravascular location of the needle tip before injecting the steroids 36. Other authors have 
advocated using CT fluoroscopy to perform TFSI because it offers better anatomic details 
reducing the risk of puncturing the VA and allows for more precise needle positioning within 
the intervertebral foramen 40-42.   
Other proposed measures to avoid serious complications include the use of a test dose 
of local anesthetic before injection of steroids, to confirm the absence of signs and symptoms 
of central nervous system hyperirritability 64, 65.  
Most interventionalists agree that TFSI should be performed without or with little 
sedation to keep the patient alert to report any unusual sensation during the procedure.  
The choice of needles has also been examined. Although blunt needles in general are 
less likely than sharp needles to puncture vital structures and produce hemorrhage, this 
distinction is less apparent with the smaller 22G or 25G needles 66. Some authors favor the use 
of 22G instead of 25G needles to decrease the risk of penetrating the smaller vessels 40. 
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2.3.2.2. The role of corticosteroids 
The risk of severe neurologic complications following TFSI is linked to the type of 
corticosteroids used and a growing body of evidence supports an embolic mechanism. In the 
study by Scanlon et al. 49 methylprednisolone, which consists of the type of corticosteroid with 
the largest particles, was most frequently involved. There is also incriminating evidence 
against triamcinolone, another particulate corticosteroid 49, 55, 59, 65, 67, 68. These types of 
corticosteroids have a tendency to coalesce into larger aggregates increasing their potential for 
embolic occlusion of the small radicular arteries during accidental intra-arterial injection 65. 
Betamethasone acetate-betamethasone sodium phosphate is another type of particulate 
corticosteroid which appears to be safer, although complications have been reported following 
its use 49. Derby et al. 69 tested different types of particulate and nonparticulate corticosteroid 
preparations in various solutions in vitro, under light microscopy (Table III). In this study, 
dexamethasone sodium phosphate demonstrated negligible particle size (approximately 10 
times smaller than red blood cells) did not appear to form aggregates and had the lowest 
density. These findings suggest that because of its high solubility and small particle size, 
dexamethasone would be less likely to cause microvascular occlusion if inadvertent intra-
arterial injection occurred in the course of a TFSI. To date, no severe adverse effects have 
been reported with the use of dexamethasone sodium phosphate in TFSI. In terms of metabolic 
activity, dexamethasone is recognized to have a rapid onset, but short duration of action 
compared to particulate corticosteroids. In a non-randomized retrospective study comparing 
the efficacy of TFSI with triamcinolone and dexamethasone at short-term follow-up, Lee et al. 
found no statistically significant difference in effectiveness between the two compounds 70. 
Similarly, in a randomized trial of 30 patients comparing the effectiveness, at 4 weeks, of a 
single TFSI with triamcinolone or dexamethasone, Dreyfuss et al. found that the yield of 
dexamethasone was slightly less than that of triamcinolone but the difference was neither 
statistically nor clinically significant 71. Hence, dexamethasone appears to be a valid 
alternative to particulate corticosteroids. 
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Table III: Size of corticosteroid particles, comparison with red blood cells (7.5 – 7.8 µm) 
Corticosteroids Dexamethasone 
sodium 
phosphate 
10mg/ml 
Triamcinolone 
acetonide 
40mg/m
l 
Methylprednisolone 
40mg/ml 
Betamethasone 
acetate-
betamethasone 
sodium phosphate 
6mg/ml 
Particle size < 7.6 µm 0.5 – 100 µm < 7.6 µm Varied 
Aggregation None Extensive Few > 100 
 Adapted from Derby et al. 69 
 
2.4. Alternative techniques to transforaminal corticosteroids 
injections 
In view of the growing body of reports of catastrophic neurologic injuries following 
TFSI, some authors have questioned its use in the treatment of cervical radiculopathy 48, 72.  As 
previously discussed, emphasis has been put on technical strategies to improve the safety of 
the technique. Alternative approaches, which potentially carry fewer risks, have also been 
advocated by some authors, even though their safety and efficacy, as is the case for TFSI, has 
yet to be validated by controlled randomized studies 48. 
2.4.1 Interlaminar epidural corticosteroid injections 
In the cervical spine, two approaches for direct delivery of corticosteroids into the 
epidural space may be used: transforaminal and interlaminar. The choice of which technique 
to use depends on the cervical pathology, the ability of the interventionalist to perform each 
technique and the efficacy versus the risks associated with each technique. The interlaminar 
route allows for more diffuse spread of the medication and is the preferred method to treat 
multilevel pathology. More localized spread of the medication and theoretically, higher 
concentration of medication is achieved with the transforaminal route and many believe that it 
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is the most effective technique to relieve the inflammation caused by mechanical or chemical 
nerve root irritation in the foramen.  
In recent years, there appears to be a renewed interest for the interlaminar epidural 
corticosteroid injections (ILSI). In 2004, Derby et al. performed a retrospective survey among 
the course instructors of the International Spine Intervention Society (ISIS) 73. Questions were 
asked regarding the type of cervical epidural injections performed for neck and / or arm pain 
and any complications during the preceding 12 months period. Seventeen out of 29 (59%) 
instructors replied. In all, they performed an estimated total of 5968 cervical epidural 
injections with 74% ILSI and 24% TFSI. Twenty-three (0.52%) cases of minor complications 
in 4389 ILSI and 5 (0.32%) cases in 1579 TFSI were reported. When performing an ILSI, 
most respondents chose either the C7-T1 or T1-T2 levels, which provide the most distance 
between the ligamentum flavum and the dural sac and is believe to be the most secure 
approach. This survey could not assess the prevalence of major complications although one 
physician reported 2 cases of radicular artery injection confirmed by digital substraction 
angiography during 354 TFSI. Although serious complications after ILSI at the cervical level 
are recognized to be exceedingly rare, some authors have reported severe complications 
following ILSI such as subdural hematoma 74, direct cord injury 75 and quadriparesis 76 
emphasizing the omnipresent risks associated with all interventional procedures. 
2.4.2 Facet joint corticosteroid injections 
IFSI are indicated for the treatment of cervical facet joint syndrome 77, 78, although 
evidence for their short-term and long-term efficacy in the cervical spine is limited 79, 80. 
The study by Kim et al. suggested that IFSI could be effective in patients with cervical 
disc herniation 1. More recently, Hwang and colleagues suggested the use of a technique of 
IFSI with intentional capsular rupture, as an alternative to epidural steroid injections for 
lumbar radiculopathy caused by spinal stenosis, in patients who are at increased risk of 
bleeding 81. The exact mechanism of this apparent beneficial effect of IFSI for the treatment of 
cervical and lumbar radiculopathy remains uncertain and unclear, but could potentially be 
explained by the proximity of the facet joint ventral capsular recess to the intervertebral 
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foramen and/or leakage of the medication from the facet joint into the epidural and/or 
foraminal spaces. 
In 1983, Dory described his technique of arthrography of the cervical facet joint 82. In 
his study, Dory showed that the ventral recess of the facet joint capsule is part of the posterior 
wall of the intervertebral foramen and may even bulge into the foramen FIGURE. 
Furthermore, in 4/21 intra-articular facet injections, Dory reported leakage of contrast in the 
epidural space or intervertebral foramen after over distention of the joint capsule. 
In our experience and that of others 81, leakage of contrast into the epidural space 
following intra-articular facet injection is not uncommon, and may occur either spontaneously 
or intentionally. In 2001, we described a percutaneous technique to treat lumbar facet joint 
synovial cysts causing lower limb radiculopathy, consisting of an IFSI combined with forceful 
injection of bupivacaine 0.5% and normal saline under image guidance, to rupture the synovial 
cyst 83. Following rupture of the cyst, dispersion of contrast into the epidural space was well 
documented either at fluoroscopy or CT. 
IFSI are procedures that are not technically challenging and can be easily performed 
with image guidance. As opposed to TFSI, IFSI are more widely available to patients because 
they are performed by a greater number of physicians.  IFSI are considered to be safe, with 
only scarce reports of complications in the literature, namely a case of septic arthritis 84 and a 
case of ‘blind’ IFSI that resulted in transient tetraplegia 85.  
 
 
  
 
Chapter 3. Hypothesis and Objectives of the Study 
3.1. Hypothesis 
Intra-articular facet steroid injections are at least as effective as transforaminal steroid 
injections or are worse by less than 15%, for the treatment of cervical radiculopathy due to 
degenerative spondylosis and/or a disc herniation. 
3.2. Primary objective 
The primary objective of this study was to compare the efficacy of CT-guided intra-
articular facet steroid injections to CT-guided transforaminal steroid injections in subjects with 
cervical radiculopathy of at least one-month duration, due to degenerative spondylosis and/or 
a disc herniation, at 4 weeks follow-up.  
3.3. Secondary objective 
The secondary objective of this study was to examine the contrast distribution patterns 
following the CT-guided intra-articular facet and transforaminal steroid injections, and to 
correlate to the pain severity outcome rated on a visual analog scale (0 – 100). 
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4.2.1. Abstract 
Background and Purpose: Transforaminal corticosteroid injections can be performed 
in the management of cervical radiculopathy but carry the risk of catastrophic complications. 
This study compares the efficacy of transforaminal and facet corticosteroid injections at 4 
weeks follow-up. 
Materials and Methods: We randomly assigned 56 subjects to receive CT-guided 
transforaminal (15 men, 13 women; mean age 52 years; range 28 – 72 years) or facet (8 men, 
20 women; mean 44 years; range 26 – 60 years) injections. The primary outcome was pain 
severity rated on a visual analog scale (0-100). Secondary outcomes were the Neck Disability 
Index and the Medication Quantitative Scale.  
Results: In the intention-to-treat and as-treated analyses, for a mean baseline score, 
facet injections demonstrated a significant pain score reduction of 45.3% (95%CI: 21.4; 69.2) 
and 37.0% (95%CI: 9.2; 64.7), while transforaminal injections showed nonsignificant pain 
score reduction of 9.8% (95%CI: +11.5; 31.2) and 17.8% (95%CI: +6.6; 42.2). While facet 
injections demonstrated an improvement in Neck Disability Index score of [24.3% (95%CI: 
+2.9; 51.5); 20.7% (95%CI: +6.2; 47.6),] as opposed to transforaminal injections [9.6% 
(95%CI: +15.2; 34.4); 12.8% (95%CI: +11.2; 36.7)], the results were not statistically 
significant. Noninferiority of facet to transforaminal injections was demonstrated for baseline 
pain score ≤ 60, while noninferiority analysis was inconclusive for baseline pain score ≥ 80 
and for the Neck Disability Index. Neither intervention showed a significant medication intake 
score reduction over time. 
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Conclusion: Facet injections are effective for the treatment of cervical radiculopathy 
and represent a valid and safer alternative to transforaminal injections. 
 
4.2.2. Abbreviation key 
TFSI = transforaminal corticosteroid injections; IFSI = intra-articular facet corticosteroid 
injections; VAS = visual analog scale; NDI = Neck Disability Index; MQS = Medication 
Quantitative Scale. 
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4.2.3. Introduction 
Cervical radiculopathy is a debilitating condition caused by the irritation of a cervical 
spinal nerve root. Patients typically present with pain radiating to the upper arm and a 
combination of sensory disorder, altered reflexes or motor weakness 1. It affects approximately 
one person per 1 000 of population per year and is most often caused by degenerative 
spondylosis and/or a disc herniation 2. Historically, approximately 30% of patients have 
required surgery 3. Most patients will be treated with medical treatment, which may include 
rest, analgesics, nonsteroidal anti-inflammatory drugs, physical therapy and corticosteroid 
injections.  
Two major mechanisms can potentially cause irritation of the spinal nerve: mediators 
of inflammation produced by degenerated discs or herniated disc material 4 and compression 
of the nerve by degenerative changes occurring at the intervertebral disc level, at the 
uncovertebral joint and/or at the facet joint. The presumed therapeutic effect of corticosteroid 
injections is the suppression of the inflammatory cascade. Transforaminal corticosteroid 
injections (TFSI) allow for delivery of a high concentration of corticosteroids directly and 
precisely at the site of the involved spinal nerve and are used to treat cervical radiculopathy 5, 
6. In the past 15 years, a significant number of catastrophic neurological complications after 
TFSI have been reported in the literature 7. Although the exact prevalence of these devastating 
adverse events is unknown, some authors have questioned the continued use of TFSI 8 while 
others advocate technical strategies to improve the safety of the procedure 9, 10 or alternative 
approaches, which potentially carry fewer risks 8.  
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The aim of this study was to compare the efficacy of intra-articular facet corticosteroid 
injections (IFSI) to TFSI in subjects with cervical radiculopathy of at least one-month 
duration, due to degenerative spondylosis and/or a disc herniation, at 4 weeks follow-up.  
4.2.4. Materials and Methods 
4.2.4.1. Subjects 
4.2.4.1.1.Recruitment  
The Research Ethics Committee of our Institution approved this study. All subjects 
received written and verbal information and gave their written consent. The study was carried 
out according to the Helsinki Declaration, was approved by the scientific committee of the 
Research Funding Agency of the Quebec Government (FRQ-S, grant # 21230 – 2) and was 
registered at the University of Montreal as part of a master’s thesis in Biomedical Science. 
Prospectively, 56 adults suffering from a cervical radiculopathy, capable of giving a 
written consent were enrolled in the study. The subjects were recruited from the hospital 
community. One of two physiatrists or one of two neurosurgeons performed a clinical 
evaluation of the subjects to confirm the diagnosis of cervical radiculopathy according to 
eligibility criteria, similar to criteria used in previous studies 5, 9, and to identify presence of 
exclusion criteria.  
The eligibility criteria were: evidence of a cervical radiculopathy involving one spinal 
nerve, of at least one month duration, refractory to medical treatment; symptoms of cervical 
pain radiating to the upper limb and signs of altered sensations, abnormal reflexes or motor 
weakness; caused by degenerative spondylosis and/or a disc herniation as documented at CT 
or MRI; current mean pain score of ≥ 6 on a verbal analog scale, of 0 (no pain) to 10 (worse 
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pain imaginable). The exclusion criteria included: evidence of vertebral fracture, tumor or 
infection of the cervical spine; treatment with cervical corticosteroid injections within the past 
3 months; coagulopathy; allergy to iodinated contrast media. One of two radiologists reviewed 
the imaging studies to confirm the presence of degenerative spondylosis and/or a disc 
herniation at the level of the involved spinal nerve and to exclude other pathology.  
4.2.4.1.2. Enrollment in the study 
The research assistant performed a telephone interview with the subjects who agreed to 
participate in the study, to discuss the research protocol in detail, to collect medical and 
demographic data and to schedule an appointment for the intervention within two weeks of 
their clinical evaluation. The subjects were informed of the risk of minor adverse effects after 
the procedure including: vasovagal reaction, increased pain at the site of injection, increased 
radicular pain, headache, dizziness, nausea, and hypersensitivity reaction, and of the very low 
risk of major complications including: infection, deep hematoma, seizures, spinal cord and 
brain infarcts, and death. Upon request, the subjects could meet with one of the researchers for 
any inquiry concerning their participation in the study. 
4.2.4.1.3. Randomization 
Patients were randomized to one of two groups: treatment with TFSI at the level of the 
involved spinal nerve root or treatment with IFSI of the facet joint adjacent to the involved 
spinal nerve root. The randomization sequence with block sizes of eight was computer 
generated by a person not otherwise directly involved with the subjects. Seven blocks of eight 
were determined to ensure a balanced distribution of subjects into each group. The envelopes 
were sealed and sequentially numbered from 1 to 56. The randomization was done without 
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stratification to allow for evaluating the demographic and clinical aspects of interest. On the 
day of the procedure, the research assistant gave the sealed envelope matching the sequential 
number of the subject, to the radiologist in charge of performing the intervention. The 
radiologist consulted the content of the envelope and resealed the envelope before returning it 
to the assistant. Hence, the assistant remained blind to the type of injection for the duration of 
the study.   
4.2.4.2. Interventions 
One of two musculoskeletal radiologists with 10 and 18 years of experience in 
interventional spine procedures performed the injections. The TFSI were performed according 
to a standard technique 9, and the IFSI were performed using a lateral approach. The setup of 
the patient, the sequential steps of the technique and the material that was used were identical, 
with the exception of the targeted site of injection, which was the posterior and lateral aspect 
of the neural foramen for the TFSI (Figure 12A), and the facet joint space for the IFSI (Figure 
12B). This method ensured that the subjects remained blind to the type of injection that they 
received. 
The subject was placed in the supine position, with his or her head turned 45 degrees to the 
contralateral side from the injection. Scout images of the targeted neural foramen were 
obtained. The skin was marked where an appropriate entry site was chosen. Then, the skin was 
prepped and draped in the usual fashion. The skin and subcutaneous tissue were anesthetized 
with lidocaine 1% (AstraZeneca, Mississauga, Canada) using a 25-gauge, 1.5-inch needle. 
Then a 22-gauge, 2.5-inch spinal needle was advanced by using intermittent CT fluoroscopy 
(Philips Brilliance-64, Amsterdam, The Netherlands), with a collimation of 2.5 mm X 4 
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images set. Once the needle was in the appropriate location, 0.5 to 1.0 ml of contrast material 
(Iohexol 240, GE Healthcare, Mississauga, Canada) was injected using a minibore tubing, 
connected to a 3cc syringe and images were acquired to exclude intra-vascular position of the 
needle and to confirm adequate distribution of the contrast material. Then, 1 ml of 
dexamethasone sodium phosphate 10mg/ml (Omega, Montreal, Canada) was injected using a 
1cc syringe. Then, the needle was withdrawn and the subject was observed for 30 minutes.  
A       B      
Figure 12. A) CT-guided transforaminal corticosteroids injection. The needle is positioned in 
the posterolateral aspect of the foramen with contrast media flowing in the foramen. B) CT-
guided intra-articular facet corticosteroids injection. The needle is positioned in the facet joint. 
Contrast media injection confirms an intra-capsular distribution. 
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4.2.4.3. Outcome measures 
The primary outcome was pain severity rated on a visual analog scale (VAS) measured 
4 weeks after the intervention. Subjects were asked to indicate their mean pain level 
experienced during the last few days on a VAS consisting of a straight line extending from 0 
(no pain) to 100 (worse pain imaginable) mm. Secondary outcome measures were the Neck 
Disability Index (NDI) 11 and the Medication Quantitative Scale (MQS) 12. The NDI is a valid 
questionnaire, which measures the impact of neck pain on everyday life activities related 
mainly to personal care, work, sleeping, driving, reading and recreation. It comprises 10 items, 
each scored from 0 (no disability) to 5 (total disability). The minimal clinically important 
difference is 5 (10%). We used the MQS to quantify medication use on a weekly basis after 
the intervention. Scores were calculated for each pain-related medication based on weights 
assigned by pharmacological class and dosage level, and summed to yield the total MQS 
score. Although the lowest possible MQS score is 0, there is no definite upper limit. The 
minimal clinically significant reduction in MQS score is 4. At baseline, subjects were 
instructed that they could continue taking their usual medication after the procedure, and were 
instructed to keep a written daily record of the type and dose of their medication intake over 
the next 4 weeks.  
4.2.4.4. Follow-up time points 
On the day of the intervention, before randomization, the subjects met with the 
research assistant at the university hospital, to sign the consent form, and to complete the 
baseline VAS and the NDI questionnaire. Thirty minutes after the intervention, the assistant 
met with the subjects to assess any immediate adverse reactions. The subjects were asked to 
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rate the worse pain experienced during the intervention and their level of pain at the current 
time, on a verbal analog scale (0-10). The assistant met again with the subjects 4 weeks after 
their procedure to complete the post-intervention VAS and the NDI questionnaire. The 
subjects were questioned about any delayed adverse effects following the procedure. The 
medication record notebooks were also collected.  
4.2.4.5. Statistical analysis 
It was determined that a sample size of fifty-six subjects, divided equally in both 
groups, would be required to detect an efficacy in VAS pain score reduction, of at least 30% in 
both groups, with a power of 80% and a type I error of 5% in two paired Student t-tests. 
Descriptive statistics were used to characterize the two subjects groups at baseline and Student 
t and chi-square tests with a two-sided alpha level of 0.05 were used to compare the 
characteristics between the two groups.  
The main analyses followed the intention-to-treat principle analyzing all patients 
according to randomization. In addition, an as-treated analysis was performed according to the 
type of injection that the subjects received. Relative differences between post-intervention and 
baseline scores were calculated for the VAS pain score and for the NDI. The clinical efficacy 
of the IFSI and TFSI, in terms of VAS pain score reduction and of NDI improvement, was 
defined as a mean of at least 30% and 10%, respectively.  For the MQS, a mean reduction of at 
least 4 in crude score was considered a significant reduction.  
The group differences in VAS pain score and NDI were analyzed using an ANCOVA 
adjusted for baseline values, age, gender, and employment status. Noninferiority of the IFSI to 
the TFSI was claimed when the mean and 95% CI of the outcome variables of IFSI were at 
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least equivalent, or worse by less than 15% the outcome variables of TFSI 13. The efficacy of 
IFSI and TFSI was also compared in terms of the MQS with a repeated measures ANOVA 
adjusted for age, gender, and employment status. Contrasts were used to test the presence of a 
linear tendency over time in each group. Statistical software used for analyses was SAS 
version 9.3 (SAS Campus Drive, North Carolina, USA).  
4.2.5. Results 
Of 165 subjects who were screened, 56 were enrolled in the study from December 1, 
2010, through September 30, 2013. The study flow chart is shown in Figure 13.   
Among the eligible subjects at screening (n=69), 81% (n=56) agreed to participate in the 
study. No subjects were lost at follow-up. Among the subjects randomized to receive an IFSI, 
one subject received a TFSI by mistake on the part of the radiologist. Among the subjects 
randomized to receive a TFSI, two subjects received an IFSI. In one case, the anterior articular 
recess of the articular facet was entered inadvertently. In the other case, the radiologist tried 
unsuccessfully to perform a TFSI at the C6 – C7 level and finally opted to perform an IFSI 
instead.  
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Figure 13. Flow diagram of the progress of subjects through the phases of the study 
 
 
165 subjects were screened 
96 (58%) were ineligible 
 83 (86%) did not meet  
 inclusion criteria 
 13 (14%) had other   
 reasons 
13 (8%) were eligible but declined to 
 participate 
56 (34%) underwent randomization 
28 (50%) allocated to IFSI 
 27 (96%) received IFSI 
 1 (4%) received TFSI 
 
28 (50%) allocated to TFSI 
 26 (93%) received TFSI 
 2 (7%) received IFSI 
 
28 (100%) were analyzed 
 
28 (100%) were analyzed 
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Subject characteristics at baseline are presented in Table IV. The baseline characteristics of the 
two groups were similar except for the age, gender, and employment status variables for which 
a significant or almost significant difference was found.  
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Table IV. Baseline characteristics of subjects (per randomization) treated either with 
transforaminal or intra-articular facet corticosteroid injections. 
 Groups P 
Value 
Variables IFSI TFSI  
Subjects, N 28 28  
Gender, N (percentage)   0.059 
Male 8 (29) 15 (54)  
Female 20 (71) 13 (46)  
Age (years), mean ± SD (range) 44 ± 8.3 (26 - 
60) 
52 ± 11.1 (29 - 
72) 
0.007 
Duration of pain (months), mean ± SD 
(range) 
14 ± 20 (1 – 84) 17 ± 21 (1 – 84) 0.649 
Imaging findings, N (percentage)   0.357 
Disc herniation 12 (43) 7 (25)  
Spondylosis 14 (50) 20 (71)  
Spondylosis/disc herniation 2 (7) 1 (4)  
Level of injection, N (percentage)   0.566 
C3 – C4 1 (4) 0 (0)  
C4 – C5 1 (4) 3 (11)  
C5 – C6 16 (57) 15 (53)  
C6 – C7 10 (35) 10 (36)  
Side of injection, N (percentage)   0.284 
Right 13 (46) 17 (61)  
Left 15 (54) 11 (39)  
VAS (0 – 100), mean ± SD (range) 61 ± 17 (23 – 
95) 
63 ± 18 (17 – 85) 0.691 
NDI (0 – 50), mean ± SD (range) 21 ± 8 (10 – 44) 19 ± 7 (5 – 30) 0.301 
Employment status, N (percentage)   0.030 
Working 12 (42.9) 16 (57.1)  
Retired 1 (3.6) 4 (14.3)  
Not working 15 (53.5) 8 (28.6)   
 On sick leave with insurance 10 (35.71) 4 (14.29)  
 On sick leave without insurance 0 (0.00) 2 (7.14)  
 Worker’s compensation 4 (14.29) 0 (0.00)  
 On welfare  1 (3.57) 2 (7.14)  
N = number; SD = standard deviation; VAS = visual analog scale; NDI = Neck Disability 
Index; TFSI = transforaminal corticosteroid injections; IFSI = intra-articular facet 
corticosteroid injections 
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The mean level of worse pain felt during the intervention was similar in both the 
intention-to-treat and as-treated analyses respectively, and at 7.1 and 7.3 for the TFSI group, 
and at 6.2 and 6.0 for the IFSI. Similarly, the mean level of cervical pain reported at 30 
minutes after the intervention was equivalent in both groups, at 3.1 in the intention-to-treat 
analysis, and at 3.2 in the as-treated analysis. No adverse events occurred following the 
interventions. At the 4-week follow-up, in the intention-to-treat analysis, one subject of the 
TFSI group reported having tinnitus and vertigo since the intervention and one subject in each 
group reported having suffered from headaches during the following two days after the 
intervention. In the as-treated analysis all the delayed adverse effects were reported in the 
TFSI group. 
4.2.5.1. Clinical efficacy of IFSI and TFSI  
In the intention-to-treat and as-treated analyses, for a mean baseline VAS pain score of 
62.4, the IFSI group demonstrated a clinically and statistically significant pain score reduction 
of 45.3% (95%CI: 21.4; 69.2) and of 37.0% (95%CI: 9.2; 64.7) respectively, while the TFSI 
group showed clinically and statistically nonsignificant pain score reduction of 9.8% (95%CI: 
+11.5; 31.2) and 17.8% (95%CI: +6.6; 42.2) respectively. While the IFSI group experienced a 
clinically significant improvement in the NDI score, both in the intention-to-treat analysis 
[24.3% (95%CI: +2.9; 51.5)] and in the as-treated analysis [20.7% (95%CI: +6.2; 47.6)], the 
results were not statistically significant. The subjects who received TFSI did not show a 
clinically nor a statistically significant improvement in the NDI score in both analyses [9.6% 
(95%CI: +15.2; 34.4); 12.8% (95%CI: +11.2; 36.7)]. For the MQS outcome, neither type of 
interventions demonstrated a significant reduction in medication intake score, overall time 
measurements. 
 48 
4.2.5.2. Analysis of group differences in efficacy 
An interaction term was found between the randomized groups and the baseline VAS 
pain score (P=0.001). Hence, the efficacy of the interventions was linked to the level of the 
baseline VAS pain score (Table V). The noninferiority analysis results for VAS pain scores 
are presented in Figure 14.  
 
Table V. Pain severity scores for intra-articular facet and transforaminal corticosteroid 
injections according to the baseline score.  
  Groups 
Variable Baseline  
VAS pain 
score  
(0-100) 
IFSI TFSI 
Subjects, N    
it  28 28 
as  29 27 
VAS%, mean (95% IC)    
 20   
it  53.3 (4.0; 102.7) +83.4 (+132.8; +34.0) 
at  41.6 (17.1; 100.3) +70.6 (+128.5; +12.7) 
 40   
it  49.5 (16.7; 82.4) +39.4 (+72.1; +6.6) 
at  39.4 (0.6; 78.2) +28.9 (+66.9; 9.2) 
 60   
it  45.8 (21.8; 69.8) 4.6 (+17.2; 26.5) 
at  37.2 (9.4; 65.0) 12.9 (+12.0; 37.8) 
 80   
it  42.0 (11.6; 72.4) 48.7 (23.3; 74.0) 
at  35.0 (+0.3; 70.4) 54.6 (25.2; 84.0) 
 95   
it  39.1 (2.7; 80.9) 81.7 (46.0; 117.3) 
at  33.4 (15.6; 82.3) 86.0 (44.1; 127.8) 
 
VAS = visual analog scale; TFSI = transforaminal corticosteroid injections; IFSI = intra-
articular facet corticosteroid injections; N = number; VAS% = relative difference between 
post-intervention and baseline VAS pain score; it = intention-to-treat analysis; at = as-treated 
analysis. 
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Figure 14. Relative visual analog scale (VAS) pain score differences between intra-articular 
facet (IFSI) and transforaminal (TFSI) corticosteroid injections, according to VAS baseline 
value with adjustment for age, gender, and employment status. The intention-to-treat (A) and 
as-treated (B) analyses are presented. Error bars indicate two-sided 95% CI. Squares indicate 
mean difference. Dotted vertical line marks the 15% margin of noninferiority. LCL = lower 
confidence limit; UCL = upper confidence limit. 
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Regarding the NDI outcome the difference in efficacy between IFSI and TFSI was 
14.6% (95% CI: +18.4; 47.7) in the intention-to-treat analysis and 7.9% (95% CI: +22.9; 38.8) 
in the as-treated analysis. Although IFSI appeared to be more effective than TFSI at reducing 
the level of disability, this difference was not statistically significant and the result regarding 
noninferiority was inconclusive. 
The difference in efficacy between the two groups in terms of MQS score over time is 
presented in Figure 15. Although the visual perception would suggest a linear tendency for 
medication intake reduction over time in the IFSI group, this trend was not statistically 
significant both in the intention-to-treat analysis (P=0.654) and in the as-treated analysis 
(P=0.441). The hypothesis of a linear tendency for medication intake reduction over time was 
also rejected for the TFSI group in both analyses (P=0.902; P=0.675). 
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Figure 15. Medication quantitative scale (MQS) scores over time adjusted for age, gender, 
and employment status, for the intra-articular facet (IFSI) and transforaminal (TFSI) 
corticosteroid injections groups. The intention-to-treat (A) and as-treated (B) analyses are 
presented. Error bars indicate two-sided 95% CI. 
 
4.2.6. Discussion 
In 1997, Persson et al., in a randomized study, demonstrated that surgery, a custom 
physical therapy treatment or the use of a cervical collar were equally effective at treating 
cervical radiculopathy 14. Since an inflammatory reaction is recognized to be at least partly 
responsible for the irritation of the spinal nerve, corticosteroids should logically be part of the 
armamentarium used to treat this entity. Furthermore, to obtain optimal results, corticosteroids 
should be delivered at high concentration, as close as technically feasible to the site of the 
lesion.  These principles provide the basis for the use of TFSI in the treatment of cervical 
radiculopathy. Notwithstanding that controlled studies demonstrating the efficacy of TFSI are 
lacking, the primary reason limiting the use of TFSI is the risk of serious complications. In an 
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effort to determine the prevalence of severe complications, Scanlon et al. 7 performed a survey 
among the members of the American Spine Society. Among 1340 members, the response rate 
was 21.4% (287). In all, 78 complications were reported including: vertebrobasilar brain 
infarcts, cervical spinal cord infarcts, and 13 deaths. Arterial embolism of particulate 
corticosteroids is the most frequently cited presumptive cause of brain and spinal cord infarcts 
15. While performing a TFSI, despite using careful and precise technique, it is possible to 
cause inadvertent injection of material into radicular arteries that feed the spinal cord 16.  
The intention of this randomized controlled study was to test the hypothesis that IFSI 
are at least as effective as TFSI for the treatment of cervical radiculopathy. Both interventions 
were equally well tolerated by the subjects and no major adverse events occurred with either 
type of intervention. For a mean baseline pain severity score, IFSI provided clinically and 
statistically significant reduction in pain at 4-week follow-up, while the improvement provided 
by TFSI was clinically and statistically nonsignificant. When comparing the efficacy of both 
interventions, an interaction with the baseline pain severity score was found. Based on these 
analyses, IFSI were more effective or at least as effective as TFSI for baseline pain severity 
scores equal or less than 60, while it could not be determined if TFSI were more effective than 
IFSI for baseline pain severity scores equal or greater than 80. Interestingly, for overall 
baseline pain severity scores between 20 and 95, IFSI provided significant relief for cervical 
radiculopathy. Conversely, TFSI appeared to be effective only in subjects presenting with 
baseline pain severity scores greater than 80. These last findings remain unclear. There was no 
relationship between the imaging findings and the baseline pain severity score, thus refuting 
the hypothesis that disc herniations could be associated with greater baseline pain severity 
than degenerative spondylosis and would respond better to TFSI. 
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Regarding the NDI outcome, while IFSI appeared to ease the accomplishment of 
specific daily activities on a clinical basis, the results did not reach statistical significance. 
When comparing the two interventions, IFSI appeared to be more effective than TFSI but the 
difference was not statistically significant. Neither intervention was associated with a 
clinically significant pain medication intake reduction over time.   
An observational study by Kim et al. in 2005, suggested that IFSI could be effective in 
patients with cervical disc herniation 17. Unfortunately, the study group appeared to be 
inhomogeneous and the methodology was incompletely described to draw any sound 
conclusions from that study. More recently, Hwang and colleagues suggested the use of a 
technique of IFSI with intentional capsular rupture, as an alternative route to deliver 
corticosteroids into the epidural space for treating lumbar radiculopathy caused by spinal 
stenosis 18. Although in our study, we did not attempt to rupture the joint capsule while 
performing IFSI, we will address the issue of the potential interaction between contrast 
distribution and the efficacy of cervical corticosteroid injections in a future retrospective 
analysis of our database.  
The exact mechanism of the apparent beneficial effect of IFSI for the treatment of 
cervical radiculopathy remains uncertain and unclear. One potential explanation is the 
proximity of the facet joint ventral capsular recess to the intervertebral foramen and/or leakage 
of the medication from the facet joint into the epidural and/or foraminal spaces. If this 
hypothetical mechanism of indirect delivery of corticosteroids to the site of pathology were 
the explanation for the efficacy of IFSI, then one would expect TFSI to provide at least 
equivalent results. In that regard, our results appear to be discordant with that of several non-
controlled, observational studies, which report good to excellent results in anywhere from 24% 
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to 76% of cases 5, 6, 19, 20. Conversely, our results are in agreement with a more recently 
published study by Anderberg et al. 21. These authors randomized 40 patients presenting with 
chronic cervical radiculopathy from degenerative spondylosis, with a mean duration of 
symptoms of 31 months, to receive one fluoroscopically guided TFSI. The treatment group 
received an injection of mepivicaïne + methylprednisolone while the control group received an 
injection of mepivicaïne + saline. There was a positive response in only 30% of the patients in 
the treatment group at 3 weeks follow-up. There were no significant differences in treatment 
results between the two groups.  
Facet joint syndrome may cause neck pain, which may radiate to the shoulders and can 
mimic cervical radiculopathy 22. We are confident that the randomized study design and the 
fact that the diagnosis of cervical radiculopathy was made by specialists based on strict 
inclusion criteria with correlative imaging findings, guarantee that the subjects in our study 
were suffering from cervical radiculopathy and that our results cannot be explained on the 
basis of a positive effect of IFSI on facet joint syndrome.    
The results of this study must be interpreted in light of some limitations. While this 
randomized study allows for evaluating the efficacy of IFSI and TFSI with a power of 80%, 
our sample size is small for a study design of noninferiority comparing both interventions, to 
prove without a doubt that IFSI are not less effective than TFSI at treating cervical 
radiculopathy. This would require a prohibitively greater number of subjects. Nevertheless, 
this study is one of the few randomized controlled trials examining the efficacy of TFSI for the 
treatment of cervical radiculopathy. This study also provides specialists who treat these 
patients and who perform these interventions, with data to consider an alternative technique, 
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which carries less risks to patients, is less technically challenging and is more widely available 
to patients. 
4.2.7. Conclusions 
IFSI are effective for the treatment of cervical radiculopathy due to spondylosis and/or 
disc herniation. IFSI were more or at least as effective as TFSI at providing pain relief when 
the baseline pain severity score was low to moderate, while the comparison between the two 
interventions remained inconclusive for severe baseline pain level. IFSI can represent a valid 
and safer alternative to TFSI as no serious complications have been reported to date with this 
approach.  
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4.3. Published manuscript 
The full text of the published manuscript: Transforaminal versus intra-articular facet 
steroid injections for the treatment of cervical radiculopathy: a randomized, double-blind, 
controlled study, is reproduced in Appendix IX with permission (Appendix VIII) from the 
licensed content publisher American Society of Neuroradiology and all co-authors. 
 
 
Chapter 5. Correlation of contrast distribution patterns 
with pain severity outcome 
 
In this chapter, we are presenting the results pertaining to the secondary objective of 
this research project. 
5.1. Introduction 
In Chapter 4 we presented the results of the randomized controlled trial and arrived at 
the conclusion that intra-articular facet steroid injections are effective for the treatment of 
cervical radiculopathy, but the exact mechanism of this apparent beneficial effect remains 
undetermined. Hypothetical mechanisms that can be considered are the anatomical proximity 
of the facet joint ventral capsular recess to the spinal nerve root in the intervertebral foramen 
and leakage of the medication from the facet joint into the epidural and/or foraminal spaces. 
Therefore, the secondary objective of our study was to examine the contrast 
distribution patterns following the intra-articular facet and transforaminal injections and to 
correlate them with the pain severity outcome in the same cohort of subjects. 
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5.2. Material and Methods 
5.2.1. Subjects 
Two musculoskeletal radiologists (Dr Moser and myself) performed a retrospective 
analysis, in consensus, of the CT scan images obtained at the time of the interventions, in the 
same population of 56 subjects with cervical radiculopathy.  
5.2.2. CT scan image analysis 
At the time of the interventions, after the injection of the steroid preparation and once the 
needle was removed, a volumetric image data set of the cervical spine, extending from at least 
one intervertebral level above the nerve that was injected down to the C7-T1 level, was 
acquired. Reconstructions with bone and soft tissue algorithms were performed. Then, 
multiplanar reconstructions in the sagittal and coronal planes with a slice thickness of 1mm 
were obtained. These CT scan studies served for image analysis and were reviewed on a 
PACS workstation. The studies were analyzed according to the as-treated protocol, which 
means according to the type of steroid injections that the subjects actually received. Contrast 
distribution was assessed and classified into different patterns: juxta-articular, intra-articular, 
intra-articular/retro-ligamentous, intra-articular/retro-ligamentous/epidural, intra-
articular/epidural/foraminal, intra-articular/retro-ligamentous/epidural/foraminal/extra-
foraminal in the case of IFSI, and as extra-foraminal, foraminal, extra-foraminal/foraminal, 
extra-foraminal/foraminal/epidural and foraminal/epidural in the case of TFSI (Figure 16).  
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Figure 16. Contrast distribution patterns. 
Illustration shows the potential spaces where contrast and steroids may spread following intra-
articular facet or transforaminal injections: intra-articular facet (single star); juxta-articular 
facet (double stars); retro-ligamentous (long arrow); epidural space (short arrow); foraminal 
space is shown between the dashed lines and the extra-foraminal space is anterolateral to the 
foramen (extra-foraminal).   
5.2.3. Statistical analysis 
Descriptive statistics were used to characterize the contrast distribution patterns in each 
group. The efficacies in terms of VAS pain score, of the contrast distribution patterns with a 
frequency greater than 2 (n = 48), were compared with an ANCOVA adjusted for the VAS 
baseline score, age, gender and employment status. Given the high number of between 
patterns comparisons, a Bonferroni correction was performed. A two-sided alpha level of 0.05 
was considered statistically significant. 
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5.3. Results 
5.3.1. Frequency of contrast distribution patterns following intra-articular 
facet and transforaminal steroid injections 
The frequency of contrast distribution patterns following IFSI and TFSI are presented 
in Table VI.  
Following IFSI, the contrast most frequently spread from the facet joint to the retro-
ligamentous space (62%) (Figure 17). In six cases (21%) of IFSI, using a lateral approach 
under CT guidance, the attempt to position the needle in the facet joint was unsuccessful. 
Instead, the needle was placed in contact with the facet joint to perform a juxta-articular facet 
injection (Figure 18). Surprisingly, contrast was seen in the foraminal and/or epidural spaces 
in only 10% of the cases following IFSI.  
Following TFSI, two contrast distribution patterns were most commonly encountered. 
Hence, the contrast spread in the extra-foraminal and foraminal spaces (Figure 19) in 41% of 
the cases and in the extra-foraminal, foraminal and epidural spaces (Figure 20) in 33% of the 
cases. In 15% of the cases, the contrast spread in the foraminal and epidural spaces (Figure 
21).  
 
 
Table VI. Frequency of contrast distribution patterns following intra-articular facet and 
transforaminal steroid injections 
 Groups 
Variables IFSI TFSI 
Subjects, N 29 27 
Contrast distribution patterns, N (percentage)   
Juxta-articular 6 (20.69)  
Intra-articular 2 (6.89)  
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Intra-articular/Retro-ligamentous 18 (62.07)  
Intra-articular/Retro-ligamentous/Epidural 1 (3.45)  
Intra-articular/Epidural/Foraminal 1 (3.45)  
Intra-articular/Retro-ligamentous/Epidural/Foraminal/Extra-
foraminal 
1 (3.45)  
Extra-foraminal  1 (3.70) 
Foraminal  2 (7.41) 
Extra-foraminal/Foraminal  11 (40.74) 
Extra-foraminal/Foraminal/Epidural  9 (33.33) 
Foraminal/Epidural  4 (14.82) 
N = number; IFSI = intra-articular facet steroid injections; TFSI = transforaminal steroid 
injections.  
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Figure 17. Intra-articular facet injection with contrast spreading in the retro-ligamentous 
space, also called retrodural space. 
(A) Axial CT image shows the needle positioned in the facet joint (arrow). (B) Axial CT 
image demonstrates contrast flowing from the facet joint to the retro-ligamentous space, 
between the ligamentum flavum and the lamina of the vertebra. (C) Coronal reconstruction CT 
image shows contrast with air (arrow) in the C4-C5 facet joint. (D) Sagittal reconstruction CT 
image shows some contrast extending into the interspinous space (arrow). 
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Figure 18. Juxta-articular facet injection. 
(A) Axial CT image shows contrast spreading outside the facet joint (arrow) at the C6-C7 
level. Coronal reconstruction CT image confirms the juxta-articular distribution of contrast 
(white arrow) and the absence of contrast outlining the facet joint (black arrow).  
 
 
Figure 19. Transforaminal injection with extra-foraminal extension of contrast. 
(A) Axial CT image demonstrates contrast flowing in the foraminal space (arrow) at the C4-
C5 level. (B) Coronal reconstruction CT image shows contrast extending in the extra-
foraminal space, along the C5 spinal nerve (arrow).  
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Figure 20. Transforaminal injection with contrast spreading in the foraminal, extra-foraminal 
and epidural spaces. 
(A) Axial CT image shows contrast in the foraminal region (arrow) at the C5-C6 level. (B) 
Coronal reconstruction CT image demonstrates contrast extending in the extra-foraminal space 
along the C6 spinal nerve (arrow). (C) Sagittal reconstruction CT image depicts contrast 
extending in the epidural space both anterior and posterior (arrows). Note that the contrast 
extends above and below the C5-C6 level that was injected.  
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Figure 21. Transforaminal injection with contrast spreading in the foraminal and epidural 
spaces. 
(A) Axial CT image shows injection of contrast in the foraminal space (long arrow) at the C5-
C6 level with contrast extending in the epidural space (short arrow). (B) Coronal 
reconstruction CT image demonstrates contrast in the foramen at C5-C6 (long arrow) as well 
as contrast extending in the C6-C7 foramen (thick arrow) and proximally in the epidural space 
(curved arrow). (C) Sagittal reconstruction CT image shows contrast extending in the posterior 
epidural space above and below the C5-C6 level (star) that was injected. 
 
5.3.2. Clinical efficacy of the contrast distribution patterns following intra-
articular facet and transforaminal steroid injections 
An interaction term was found between the contrast distribution patterns and the 
baseline VAS pain score (P < 0.0001). Hence, the clinical efficacy of the interventions based 
on the contrast distribution patterns, was linked to the level of VAS pain score at baseline. 
Given the small number of subjects with a specific contrast distribution pattern, in each 
category of baseline VAS pain score (20, 40, 60, 80, 95), these results are less reliable and 
should be interpreted with caution. In this analysis, the general trend was for the juxta-articular 
and intra-articular/retro-ligamentous contrast distribution patterns following IFSI to provide 
pain relief at baseline VAS pain score ≤ 60, and for the extra-foraminal/foraminal contrast 
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distribution pattern following TFSI to provide pain relief at baseline VAS pain score of 80 and 
95. Additionally, the clinical efficacy of the contrast distribution patterns following IFSI and 
TFSI for a mean baseline VAS pain score of 62.90, are presented in Table VII.  
 
Table VII. Clinical efficacy of contrast distribution patterns for a mean baseline VAS pain 
score 
  Groups 
Variables Subjects, N IFSI TFSI 
Contrast distribution patterns  
VAS%, mean (%95 CI) 
   
Juxta-articular 6 47.0 (84.3; 9.7)   
Intra-articular/Retro-ligamentous 18 18.5 (44.2; +7.3)  
Extra-foraminal/Foraminal 11  16.6 (44.5; +11.3) 
Extra-foraminal/Foraminal/Epidural 9  22.6 (55.3; +10.1) 
Foraminal/Epidural 4  +35.5 (1.2; +72.3) 
VAS% = relative difference between post-intervention and baseline VAS pain score; N = 
subjects; IFSI = intra-articular facet steroid injections; TFSI = transforaminal steroid 
injections.  
 
5.3.3. Analysis of contrast distribution patterns differences in clinical 
efficacy  
The difference in clinical efficacy in terms of VAS pain score, between all contrast 
distribution patterns following IFSI and TFSI, was compared for all baseline VAS pain score 
levels. The statistically significant results of this analysis are presented exclusively in Table 
VIII. For baseline VAS pain score ≤ 60, the contrast distribution pattern Foraminal/Epidural 
following TFSI was significantly less effective than the other contrast distribution patterns. All 
other comparisons between the various contrast distribution patterns did not show any 
significant difference.  
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Table VIII. Difference in clinical efficacy between the contrast distribution patterns following 
IFSI and TFSI: statistically significant results 
Variables P value 
Baseline  
VAS pain 
score  
(0-100) 
Contrast distribution 
patterns  
 
Contrast distribution 
patterns  
 
VAS% difference, 
mean (%95 CI) 
 
20 Juxta-articular Foraminal/Epidural 237.3 (384.8; 91.1) 0.024 
20 Intra-articular/Retro-
ligamentous 
Foraminal/Epidural 310.7 (394.7; 226.7) <0.0001 
20 Extra-
foraminal/Foraminal 
Foraminal/Epidural 227.3 (312.1; 142.5) <0.0001 
20 Extra-
foraminal/Foraminal
/Epidural 
Foraminal/Epidural 273.3 (412.2; 134.4) 0.004 
40 Juxta-articular Foraminal/Epidural 165.5 (257.0; 73.94) 0.009 
40 Intra-articular/Retro-
ligamentous 
Foraminal/Epidural 191.0 (246.3; 135.7) <0.0001 
40 Extra-
foraminal/Foraminal 
Foraminal/Epidural 145.6 (200.2; 91.0) <0.0001 
40 Extra-
foraminal/Foraminal
/Epidural 
Foraminal/Epidural 173.0 (259.0; 87.0) 0.003 
60 Juxta-articular Foraminal/Epidural 93.01 (150.5; 35.5) 0.024 
60 Intra-articular/Retro-
ligamentous 
Foraminal/Epidural 71.3 (120.4; 22.3) 0.057 
VAS = visual analog scale; VAS% difference = difference in relative VAS pain score between 
contrast distribution patterns;  
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5.4 Discussion 
Few studies have investigated the imaging findings predictive of a favorable outcome 
following either, facet joint injections 89 for the treatment of facet joint syndrome, or 
transforaminal injections 90 for the treatment of cervical radiculopathy, while two studies have 
examined the imaging characteristics of contrast distribution after image guided injections 89, 
91 in the cervical spine. 
In this study, contrary to our expectations, extension of contrast into the foraminal 
and/or epidural spaces following IFSI occurred rarely, in only 3 / 29 cases. In fact, we 
demonstrated that contrast spread most commonly (18 / 29 cases) from the facet joint to the 
retro-ligamentous space. As cited by Murthy et al. 14, this potential space is called the 
retrodural space of Okada after the physician who described it in 1981 15. Hence, via this 
extradural space located dorsal to the ligamentum flavum, the facet joint can communicate 
with the interlaminar region, interspinous region and contralateral facet joint.  
We showed that following TFSI, contrast spread preferentially from the foramen to the 
extra-foraminal space or from the foramen to both the extra-foraminal and epidural spaces (20 
/ 27 cases). Our findings also corroborate that of a previous study 91, which showed that 
contrast can diffuse within the epidural space and reach more than one intervertebral levels as 
well as more than one intervertebral foramen even with small volumes of injection.  
Given the relatively small number of cases in each contrast distribution patterns, it is 
difficult to draw any sound conclusions on the correlation between the efficacy of the 
injections and the contrast distribution patterns. In the case of IFSI, a juxta-articular injection 
or an intra-articular injection with extension of contrast along the retro-ligamentous space 
appeared to be beneficial. In the case of TFSI, a foraminal injection with epidural spread of 
contrast appeared to be the least effective of all contrast distribution patterns, at least for low 
to intermediate baseline pain levels.  
 
  
 
Conclusion 
Intra-articular facet steroid injections are a valid alternative to transforaminal steroid 
injections for the treatment of cervical radiculopathy. Considering that intra-articular facet 
injections are easier to perform and most importantly, are safer than transforaminal injections, 
we suggest that, within an optimized medical treatment management, corticosteroid injections 
should initially be performed using an intra-articular facet approach instead of a 
transforaminal approach. 
Our results have shown that following intra-articular facet injections, contrast will 
spread preferentially from the facet joint to the retrodural space. Notwithstanding the exact 
mechanism of the apparent efficacy of intra-articular facet injections for the treatment of 
cervical radiculopathy remains unclear, leakage of corticosteroids from the facet joint into the 
foraminal and/or epidural spaces does not appear to be a causative factor.  
Our results suggest that extension of contrast in the epidural space following 
transforaminal injections could be predictive of a negative outcome. One possible explanation 
could be that dispersion of corticosteroids in the epidural space could lead to over dilution thus 
decreasing the potency of the medication.  
Cervical radiculopathy is a debilitating condition. Its physiopathology is complex. 
Injection of corticosteroids in the cervical spine can be performed using different image-
guided techniques, although some approaches carry more risks than others. This study 
supports the use of intra-articular facet steroid injections for the treatment of cervical 
radiculopathy but raises many questions as to the mechanism of their therapeutic effect. 
Evidently, to achieve better care of these patients, we need to improve our understanding of 
the mediators of pain associated with cervical radiculopathy.  
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ABSTRACT
BACKGROUNDAND PURPOSE: Transforaminal corticosteroid injections can be performed in themanagement of cervical radiculopathy
but carry the risk of catastrophic complications. This study compares the efficacy of transforaminal and facet corticosteroid injections at
4 weeks’ follow-up.
MATERIALS AND METHODS: We randomly assigned 56 subjects to receive CT-guided transforaminal (15 men, 13 women; mean age, 52
years; range, 28–72 years) or facet (8 men, 20 women; mean, 44 years; range, 26–60 years) injections. The primary outcome was pain
severity rated on a Visual Analog Scale (0–100). Secondary outcomes were the Neck Disability Index and the Medication Quantitative
Scale.
RESULTS: In the intention-to-treat and as-treated analyses, for a mean baseline score, facet injections demonstrated a significant pain
score reduction of 45.3% (95% CI, 21.4–69.2) and 37.0% (95% CI, 9.2–64.7), while transforaminal injections showed a nonsignificant pain
score reduction of 9.8% (95% CI,!11.5–31.2) and 17.8% (95% CI,!6.6–42.2). While facet injections demonstrated an improvement in the
Neck Disability Index score of 24.3% (95% CI, !2.9–51.5) and 20.7% (95% CI, !6.2–47.6) as opposed to transforaminal injections of 9.6%
(95% CI,!15.2–34.4) and 12.8% (95% CI,!11.2–36.7), the results were not statistically significant. Noninferiority of facet to transforaminal
injectionswas demonstrated for baseline pain scores of!60, while noninferiority analysis was inconclusive for baseline pain scores of"80
and for the Neck Disability Index. Neither intervention showed a significant medication-intake score reduction with time.
CONCLUSIONS: Facet injections are effective for the treatment of cervical radiculopathy and represent a valid and safer alternative to
transforaminal injections.
ABBREVIATIONS: IFSI" intra-articular facet corticosteroid injection; NDI" Neck Disability Index; MQS"Medication Quantitative Scale; TFSI" transforaminal
corticosteroid injection; VAS" Visual Analog Scale
Cervical radiculopathy is a debilitating condition caused by theirritation of a cervical spinal nerve root. Patients typically
present with pain radiating to the upper arm and a combination
of sensory disorder, altered reflexes, ormotor weakness.1 It affects
approximately 1 person per 1000 of population per year and is
most often caused by degenerative spondylosis and/or a disk her-
niation.2 Historically, approximately 30% of patients have re-
quired surgery.3Most patients will be treatedmedically, including
rest, analgesics, nonsteroidal anti-inflammatory drugs, physical
therapy, and corticosteroid injections.
Disk herniation and degenerative changes occurring at the in-
tervertebral disk level, the uncovertebral joint, and/or the facet
joint can potentially irritate the spinal nerve root by 2 major
mechanisms: production of mediators of inflammation4 and
compression of the nerve. The presumed therapeutic effect of
corticosteroid injections is the suppression of the inflammatory
cascade. Transforaminal corticosteroid injections (TFSI) allow
delivery of a high concentration of corticosteroids directly and
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precisely at the site of the involved spinal nerve and are used to
treat cervical radiculopathy.5,6 In the past 15 years, a significant
number of catastrophic neurologic complications after TFSI have
been reported in the literature.7 Although the exact prevalence of
these devastating adverse events is unknown, some authors have
questioned the continued use of TFSI,8 while others advocate
technical strategies to improve the safety of the procedure9,10 or
alternative approaches, which potentially carry fewer risks.8,11
Preliminary work by Kim et al in 200512 and by Richarme et al
in 200811 suggested that intra-articular facet steroid injections
(IFSIs) could be effective in patients with cervical radiculopathy
secondary to disk herniation. Anatomically, the facet joint ventral
recess is in close proximity to the spinal nerve root. Furthermore,
Richarme et al11 suggested that leakage of contrast into the fora-
men could be a potential mechanism of action. Therefore, using a
facet joint injection approach to deliver corticosteroids in the vi-
cinity of the injured spinal nerve root appears to be a viable alter-
native to the riskier transforaminal approach.
Wehypothesized that IFSI couldbe at least as effective asTFSI for
the treatment of cervical radiculopathy, and we devised this study to
compare, at 4 weeks’ follow-up, the efficacy of IFSI with TFSI in
subjects with cervical radiculopathy of at least 1 month’s duration
due to degenerative spondylosis and/or a disk herniation.
MATERIALS AND METHODS
Subjects
Recruitment. The Research Ethics Committee of our institution
approved this study. All subjects received written and verbal infor-
mation and gave their written consent. The study was performed
according to theDeclaration ofHelsinki, was approved by the scien-
tific committee of the Research FundingAgency of theQuebecGov-
ernment (grant 21230–2), and was registered at the University of
Montreal as part of a master’s thesis in biomedical science.
Prospectively, 56 adults with cervical radiculopathy, capa-
ble of giving written consent, were enrolled in the study. The
subjects were recruited from the hospital community. One of 2
physiatrists or 1 of 2 neurosurgeons performed a clinical eval-
uation of the subjects to confirm the diagnosis of cervical ra-
diculopathy according to eligibility criteria, similar to criteria
used in previous studies,5,9 and to identify the presence of
exclusion criteria.
The eligibility criteriawere the following: evidence of a cervical
radiculopathy involving 1 spinal nerve of at least 1 month’s dura-
tion refractory to medical treatment; symptoms of cervical pain
radiating to the upper limb; and signs of altered sensations, ab-
normal reflexes, or motor weakness caused by degenerative spon-
dylosis and/or disk herniation as documented at CT orMR imag-
ing and a current mean pain score of!6 on a Verbal Analog Scale
of 0 (no pain) to 10 (worse pain imaginable). The exclusion cri-
teria were the following: evidence of vertebral fracture, tumor, or
infection of the cervical spine; treatment with cervical corticoste-
roid injections within the past 3 months; coagulopathy; and al-
lergy to iodinated contrast media. One of 2 radiologists reviewed
the imaging studies to confirm the presence of degenerative spon-
dylosis and/or a disk herniation at the level of the involved spinal
nerve and to exclude other pathology.
Enrollment in the Study. The research assistant performed a tele-
phone interviewwith the subjects who agreed to participate in the
study, to discuss the research protocol in detail, to collect medical
and demographic data, and to schedule an appointment for the
intervention within 2 weeks of their clinical evaluation. The sub-
jects were informed of the risk of minor adverse effects and of
major complications after the procedure. On request, the subjects
couldmeet with one of the researchers for any inquiry concerning
their participation in the study.
Randomization. Patients were randomized to 1 of 2 groups:
treatment with TFSI at the level of the involved spinal nerve root
or treatment with IFSI of the facet joint adjacent to the involved
spinal nerve root. The randomization sequencewith block sizes of
8 was computer-generated by a person not otherwise directly in-
volved with the subjects. The envelopes were sealed and sequen-
tially numbered from 1 to 56. The randomization was done with-
out stratification to allow evaluating the demographic and clinical
aspects of interest. On the day of the procedure, the research as-
sistant gave the sealed envelope matching the sequential number
of the subject to the radiologist in charge of performing the inter-
vention. The radiologist checked the content of the envelope and
resealed the envelope before returning it to the assistant. Hence,
the assistant remained blinded to the type of injection for the
duration of the study.
Interventions
One of 2 musculoskeletal radiologists with 10 and 18 years of
experience in interventional spine procedures performed the in-
jections. The TFSIs were performed according to a standard tech-
nique,9 and the IFSIs were performed by using a lateral approach.
The setup of the patient, the sequential steps of the technique, and
thematerial usedwere identical, with the exception of the targeted
site of injection, which was the posterior and lateral aspects of the
neural foramen for the TFSI (Fig 1A) and the facet joint space for
the IFSI (Fig 1B). Thismethod ensured that the subjects remained
blinded to the type of injection they received.
The subject was placed in the supine position, with his or her
head turned 45° to the side contralateral to the injection. Scout
images of the targeted neural foramen were obtained. The appro-
priate entry site was marked on the skin. Then, the skin was
prepped and draped in the usual fashion. The skin and subcuta-
neous tissue were anesthetized with lidocaine 1%. Then, a 22-
ga, 2.5-inch spinal needle was advanced by using intermittent
CT fluoroscopy (Brilliance-64; Philips Healthcare, Best, the
Netherlands) with a collimation of 2.5 mm ! 4 images set.
Once the needle was in the appropriate location, 0.5–1.0 mL of
contrast material (iohexol, Omnipaque 240; GE Healthcare
Canada, Mississauga, Canada) was injected by using minibore
tubing connected to a 3-mL syringe; and at the end of the
injection, CT fluoroscopy images were acquired by the radiol-
ogist to exclude an intravascular position of the needle and to
confirm adequate distribution of the contrast material. Then, 1
mL of dexamethasone sodium phosphate, 10 mg/mL was in-
jected by using a 1-mL syringe. Then, the needle was with-
drawn and the subject was observed for 30 minutes.
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Outcome Measures
The primary outcome was pain severity rated on a Visual Analog
Scale (VAS) measured 4 weeks after the intervention. Subjects
were asked to indicate themean pain level experienced during the
past few days on aVAS consisting of a straight line extending from
0 (no pain) to 100 mm (worse pain imaginable). Secondary out-
come measures were the Neck Disability Index (NDI)13 and the
Medication Quantitative Scale (MQS).14 The NDI is a valid ques-
tionnaire, which measures the impact of neck pain on everyday
life activities relatedmainly to personal care, work, sleeping, driv-
ing, reading, and recreation. It comprises 10 items, each scored
from0 (no disability) to 5 (total disability). Theminimal clinically
important difference is 5 (10%). We used
the MQS to quantify medication use on a
weekly basis after the intervention. Scores
were calculated for each pain-related
medication based on weights assigned by
pharmacologic class and dosage level and
were summed to yield the total MQS
score. Although the lowest possible MQS
score is 0, there is no definite upper limit.
The minimal clinically significant reduc-
tion in MQS score is 4. At baseline, sub-
jects were instructed to continue taking
their usual medication after the proce-
dure and to keep a written daily record of
the type and dose of their medication in-
take during the next 4 weeks.
Follow-Up Time Points
On the day of the intervention, before
randomization, the subjects met with the
research assistant at the university hospi-
tal to sign the consent form and to com-
plete the baseline VAS and the NDI
questionnaire. Thirty minutes after the
intervention, the assistant met with the
subjects to assess any immediate adverse
reactions. The subjects were asked to
rate the worst pain experienced during
the intervention and their level of pain at
the current time on a Verbal Analog Scale
(0–10). The assistant met again with the
subjects 4 weeks after their procedure to
complete the postintervention VAS and
the NDI questionnaire. The subjects were
questioned about any delayed adverse
effects following the procedure. Themed-
ication record notebooks were also
collected.
Statistical Analysis
It was determined that a sample size of 56
subjects, divided equally into the 2
groups, would be required to detect an ef-
ficacy in VAS pain score reduction of at
least 30% in both groups, with a power of
80% and a type I error of 5% in 2 paired
Student t tests. Descriptive statistics were used to characterize the
2 subject groups at baseline, and the Student t and !2 tests with a
2-sided " level of .05 were used to compare the characteristics
between the 2 groups.
The main analyses followed the intention-to-treat principle,
analyzing all patients according to randomization. In addition, an
as-treated analysis was performed according to the type of injec-
tion the subjects received. Relative differences between postinter-
vention and baseline scores were calculated for theVASpain score
and theNDI. The clinical efficacy of the IFSI and TFSI, in terms of
VAS pain score reduction and NDI improvement, was defined as
FIG 1. A, CT-guided transforaminal corticosteroid injection. The needle is positioned in the
posterolateral aspect of the foramen with contrast media flowing in the foramen. B, CT-guided
intra-articular facet corticosteroids injection. The needle is positioned in the facet joint. Con-
trast media injection confirms an intracapsular distribution.
FIG 2. Flow diagram of the progress of subjects through the phases of the study.
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means of at least 30%and 10%, respectively. For theMQS, amean
reduction of at least 4 in the crude score was considered a signif-
icant reduction.
The group differences in the VAS pain score and NDI were
analyzed by using an ANCOVA adjusted for baseline values, age,
sex, and employment status.Noninferiority of the IFSI to theTFSI
was claimed when themean and 95%CI of the outcome variables
of the IFSI were at least equivalent to or worse by!15% than the
outcome variables of TFSI.15 The efficacy of IFSI and TFSI was
also compared in terms of the MQS with a repeated measures
ANOVA adjusted for age, sex, and employment status. Contrasts
were used to test the presence of a linear tendency with time in
each group. Statistical software used for analyseswas SAS,Version
9.3 (SAS Institute, Cary, North Carolina).
RESULTS
Of 165 subjects who were screened, 56
were enrolled in the study from Decem-
ber 1, 2010, through September 30,
2013. The study flow chart is shown in
Fig 2.
Among the eligible subjects at
screening (n " 69), 81% (n " 56)
agreed to participate in the study. No
subjects were lost to follow-up. Among
the subjects randomized to receive an
IFSI, 1 subject received a TFSI by a mis-
take of the radiologist. Among the sub-
jects randomized to receive a TFSI, 2
subjects received an IFSI. In 1 case, the
anterior recess of the articular facet was
entered inadvertently. In the other case,
the radiologist tried unsuccessfully to
perform a TFSI at the C6–C7 level and
finally opted to perform an IFSI instead.
Subject characteristics at baseline are
presented in Table 1. The baseline charac-
teristics of the 2 groups were similar ex-
cept for age, sex, and employment status
variables, for which a significant or al-
most-significant difference was found. In
addition, those receiving TFSI had an ap-
parent higher percentage with spondylo-
sis (71%) compared with disk herniation
(25%), while the subjects receiving IFSI had a more even distri-
bution with spondylosis at 50% compared with disk herniation at
43%.
The mean level of worst pain felt during the intervention was
similar in both the intention-to-treat and as-treated analyses re-
spectively, at 7.1 and 7.3 for the TFSI group and 6.2 and 6.0 for the
IFSI group. Similarly, the mean level of cervical pain reported at
30 minutes after the intervention was equivalent in both groups,
at 3.1 in the intention-to-treat analysis and 3.2 in the as-treated
analysis. No adverse events occurred following the interventions.
At the 4-week follow-up, in the intention-to-treat analysis, 1 sub-
ject of the TFSI group reported having tinnitus and vertigo since
the intervention and 1 subject in each group reported having
headaches during the 2 days following the intervention. In the
as-treated analysis, all the delayed adverse effects were reported in
the TFSI group.
Clinical Efficacy of IFSI and TFSI
The clinical efficacy of IFSI and TFSI, in terms of VAS pain
score reduction for a mean baseline VAS pain score of 62.4 and
of NDI improvement, is presented in Table 2. Regarding the
MQS outcome, neither type of intervention demonstrated a
significant reduction in the medication-intake score for all
time measurements.
We also performed a subgroup analysis of the etiologic imag-
ing findings for IFSI and TFSI in terms of VAS pain score reduc-
tion to discern any difference between apparently more acute
Table 1: Baseline characteristics of subjects (per randomization) treated with either
transforaminal or intra-articular facet corticosteroid injections
Variables
Groups
P ValueIFSI TFSI
Subjects (No.) 28 28
Sex (No.) (%) .059
Male 8 (29) 15 (54)
Female 20 (71) 13 (46)
Age (yr) (mean) (range) 44# 8.3 (26–60) 52# 11.1 (29–72) .007
Duration of pain (mo) (mean) (range) 14# 20 (1–84) 17# 21 (1–84) .649
Imaging findings (No.) (%) .357
Disk herniation 12 (43) 7 (25)
Spondylosis 14 (50) 20 (71)
Spondylosis/disk herniation 2 (7) 1 (4)
Level of injection (No.) (%) .566
C3–C4 1 (4) 0 (0)
C4–C5 1 (4) 3 (11)
C5–C6 16 (57) 15 (53)
C6–C7 10 (35) 10 (36)
Side of injection (No.) (%) .284
Right 13 (46) 17 (61)
Left 15 (54) 11 (39)
VAS (0–100) (mean) (range) 61# 17 (23–95) 63# 18 (17–85) .691
NDI (0–50) (mean) (range) 21# 8 (10–44) 19# 7 (5–30) .301
Employment status (No.) (%) .030
Working 12 (42.9) 16 (57.1)
Retired 1 (3.6) 4 (14.3)
Not working 15 (53.5) 8 (28.6)
On sick leave with insurance 10 (35.71) 4 (14.29)
On sick leave without insurance 0 (0.00) 2 (7.14)
Workers’ compensation 4 (14.29) 0 (0.00)
On welfare 1 (3.57) 2 (7.14)
Table 2: Pain severity and Neck Disability Index scores for intra-
articular facet and transforaminal corticosteroid injections
Variable
Groups
IFSI TFSI
Subjects (No.)
It 28 28
At 29 27
VAS% (mean) (95% CI)
It 45.3 (21.4–69.2) 9.8 ($11.5–31.2)
At 37.0 (9.2–64.7) 17.8 ($6.6–42.2)
NDI% (mean) (95% CI)
It 24.3 ($2.9–51.5) 9.6 ($15.2–34.4)
At 20.7 ($6.2–47.6) 12.8 ($11.2–36.7)
Note:—VAS% indicates the relative difference between postintervention and base-
line VAS pain scores; NDI%, the relative difference between postintervention and
baseline Neck Disability Index scores; It, intention-to-treat analysis; At, as-treated
analysis.
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(disk herniation) and more chronic (spondylosis) causal factors.
These results are presented in Table 3.
Analysis of Group Differences in Efficacy
An interaction term was found between the randomized groups
and the baseline VAS pain score (P! .001). Hence, the efficacy of
the interventions was linked to the level of the baseline VAS pain
score (Table 4). The noninferiority analysis results for VAS pain
scores are presented in Fig 3.
Regarding the NDI outcome, the difference in efficacy be-
tween IFSI and TFSI was 14.6% (95% CI, "18.4–47.7) in the
intention-to-treat analysis and 7.9% (95%CI,"22.9–38.8) in the
as-treated analysis. Although IFSI appeared to be more effective
thanTFSI at reducing the level of disability, this differencewas not
statistically significant and the result regarding noninferiority was
inconclusive.
The difference in efficacy between the 2 groups in terms of the
MQS score with time is presented in Fig 4. Although the visual
perceptionwould suggest a linear tendency formedication-intake
reduction during the time in the IFSI group, this trend was not
statistically significant both in the intention-to-treat analysis (P!
.654) and in the as-treated analysis (P !
.441). The hypothesis of a linear tendency
for medication-intake reduction with
time was also rejected for the TFSI group
in both analyses (P! .902, P! .675).
DISCUSSION
In 1997, Persson et al,16 in a randomized
study, demonstrated that surgery, a cus-
tom physical therapy treatment, or the
use of a cervical collar were equally effec-
tive at treating cervical radiculopathy. Be-
cause an inflammatory reaction is recog-
nized as at least partly responsible for the irritation of the spinal
nerve, corticosteroids should logically be part of the armamentar-
ium used to treat this entity. Furthermore, to obtain optimal re-
sults, corticosteroids should be delivered at a high concentration
as close as technically feasible to the site of the lesion. These prin-
ciples provide the basis for the use of TFSI in the treatment of
cervical radiculopathy. Notwithstanding that controlled studies
demonstrating the efficacy of TFSI are lacking, the primary reason
limiting the use of TFSI is the risk of serious complications. In an
effort to determine the prevalence of severe complications, Scan-
lon et al7 performed a survey among the members of the Ameri-
can Spine Society. Among 1340 members, the response rate was
21.4% (287). In all, 78 complications were reported, including
vertebrobasilar brain infarcts, cervical spinal cord infarcts, and 13
deaths. Arterial embolism of particulate corticosteroids is the
most frequently cited presumptive cause of brain and spinal cord
infarcts.17 While performing a TFSI, despite using a careful and
precise technique, one can possibly cause inadvertent injection of
material into radicular arteries that feed the spinal cord.18
The intention of this randomized controlled study was to test
the hypothesis that IFSIs are at least as effective as TFSIs for the
treatment of cervical radiculopathy. Both interventions were
equally well tolerated by the subjects, and nomajor adverse events
occurred with either type of intervention. For a mean baseline
pain severity score, IFSI provided a clinically and statistically sig-
nificant reduction in pain at 4 weeks’ follow-up, while the im-
provement provided by TFSI was clinically and statistically non-
significant. Furthermore, the subgroup analyses suggested that
IFSIs were effective in subjects with cervical radiculopathy sec-
ondary to a disk herniation and maybe to a lesser degree in sub-
jects with degenerative spondylosis, while TFSIs did not appear to
provide significant relief in both subgroups. When we compared
the efficacy of both interventions, an interaction with the baseline
pain severity score was found. On the basis of these analyses, IFSIs
were more effective or at least as effective as TFSIs for baseline
pain severity scores of!60, while whether TFSIs weremore effec-
tive than IFSIs for baseline pain severity scores of"80 could not
be determined.Most interesting, for overall baseline pain severity
scores between 20 and 95, IFSI provided significant relief for cer-
vical radiculopathy. Conversely, TFSI appeared to be effective
only in subjects presenting with baseline pain severity scores of
#80. These last findings remain unclear. There was no relation-
ship between the imaging findings and the baseline pain severity
score, thus refuting the hypothesis that disk herniations could be
Table 3: Pain severity subgroup analysis of the etiologic imaging findings for intra-
articular facet and transforaminal corticosteroid injections
Variable
Subgroups
Disk Herniation! Spondylosis Spondylosis
IFSI TFSI IFSI TFSI
Subjects (No.)
It 14 8 14 20
At 13 9 16 18
VAS% (mean) (95% CI)
It 65.0 (31.2–98.9) 8.0 ("20.2–36.2) 30.1 (0.4–59.7) "1.6 ("33.7–30.4)
At 46.5 (9.4–83.6) 22.7 ("6.6–51.9) 23.6 ("6.7–53.9) 5.6 ("27.1–38.2)
Note:—VAS% indicates the relative difference between postintervention and baseline VAS pain scores; It, intention-
to-treat analysis; At, as-treated analysis.
Table 4: Pain severity scores for intra-articular facet and
transforaminal corticosteroid injections according to the
baseline score
Variable and Baseline
VAS Pain Score
(0–100)
Groups
IFSI TFSI
Subjects (No.)
It 28 28
At 29 27
VAS% (mean) (95% CI)
20
It 53.3 (4.0–102.7) "83.4 ("132.8 to"34.0)
At 41.6 (17.1–100.3) "70.6 ("128.5 to"12.7)
40
It 49.5 (16.7–82.4) "39.4 ("72.1 to"6.6)
At 39.4 (0.6–78.2) "28.9 ("66.9–9.2)
60
It 45.8 (21.8–69.8) 4.6 ("17.2–26.5)
At 37.2 (9.4–65.0) 12.9 ("12.0–37.8)
80
It 42.0 (11.6–72.4) 48.7 (23.3–74.0)
At 35.0 ("0.3–70.4) 54.6 (25.2–84.0)
95
It 39.1 (2.7–80.9) 81.7 (46.0–117.3)
At 33.4 (15.6–82.3) 86.0 (44.1–127.8)
Note:—VAS% indicates the relative difference between postintervention and base-
line VAS pain scores; It, intention-to-treat analysis; At, as-treated analysis.
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associated with greater baseline pain severity than degenerative
spondylosis and would respond better to TFSI.
Regarding the NDI outcome, while IFSI appeared to ease the
performance of specific daily activities on a clinical basis, the re-
sults did not reach statistical significance.When we compared the
2 interventions, IFSI appeared to bemore effective than TFSI, but
the difference was not statistically signifi-
cant. Neither intervention was associated
with a clinically significant pain medica-
tion–intake reduction with time.
An observational study by Kim et al in
200512 suggested that IFSI could be effec-
tive in patients with cervical disk hernia-
tion. Unfortunately, the study group ap-
peared to be inhomogeneous and the
methodology was incompletely described
for drawing any sound conclusions from
that study. In 2007, Richarme et al19 pre-
sented preliminary results on contrast
distribution following CT-guided intra-
articular facet injections in 31 patients.
Using this alternative approach, they ob-
tained foraminal opacification in 21/31
(68%) patients and epidural opacification
in 19/31 (63%). The following year, the
same investigators presented their pre-
liminary results on the efficacy of CT-
guided IFSI in 17 patients with cervical
radiculopathy secondary to a disk hernia-
tion.11 They obtained pain relief of!50%
on a visual analog pain scale in 7/17 (41%)
patients and reported extension of con-
trast in the foraminal space in 5/7 patients
with!50% pain relief.
The exact mechanism of the apparent
beneficial effect of IFSI for the treatment
of cervical radiculopathy remains uncer-
tain and unclear. As these studies suggest,
1 potential explanation is the proximity of
the facet joint ventral capsular recess to
the intervertebral foramen and/or leakage
of themedication from the facet joint into
the epidural and/or foraminal spaces. If
this hypotheticmechanism of indirect de-
livery of corticosteroids to the site of pa-
FIG 3. Relative Visual Analog Scale pain score differences between intra-articular facet and
transforaminal corticosteroid injections, according to the VAS baseline value with adjustments
for age, sex, and employment status. The intention-to-treat (A) and as-treated (B) analyses are
presented. Error bars indicate 2-sided 95% CIs. Squares indicate mean differences. The dotted
vertical line marks the 15% margin of noninferiority. LCL indicates lower confidence limit; UCL,
upper confidence limit.
FIG 4. Medication Quantitative Scale scores with time adjusted for age, sex, and employment status, for the intra-articular facet and
transforaminal corticosteroid injections groups. The intention-to-treat (A) and as-treated (B) analyses are presented. Error bars indicate 2-sided
95% CIs.
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thology were the explanation for the efficacy of IFSI, then one
would expect TFSI to provide at least equivalent results. In that
regard, our results appear to be discordant with those of several
noncontrolled, observational studies, which reported good-to-
excellent results in anywhere from 24% to 76% of cases,5,6,20,21
including a more recent prospective case series study of 140 pa-
tients with chronic cervical radiculopathy due to degenerative
spondylosis who received 3 consecutive TFSIs at 3-week inter-
vals.22 These authors reported a significant pain reduction in 49%
(69/140) of their patients at 12–14 weeks’ follow-up.
Conversely, our results are in agreement with a randomized
controlled study by Anderberg et al.23 These authors assigned 40
patients presenting with chronic cervical radiculopathy from de-
generative spondylosis, with a mean duration of symptoms of 31
months, to receive 1 fluoroscopically guided TFSI. The treatment
group received an injection of mepivacaine and methylpred-
nisolone, while the control group received an injection of mepi-
vacaine and saline. There was a positive response in only 30%
(6/20) of the patients in the treatment group at 3 weeks’ follow-
up. There were no significant differences in treatment results be-
tween the 2 groups.
The results of this study must be interpreted in light of some
limitations. Facet joint syndrome may cause neck pain, which
may radiate to the shoulders and can mimic cervical radiculopa-
thy.24We are confident that the randomized study design and the
diagnosis of cervical radiculopathy made by specialists based on
strict inclusion criteria with correlative imaging findings guaran-
tee that the subjects in our study had cervical radiculopathy and
that our results cannot be explained on the basis of a positive effect
of IFSI on facet joint syndrome. While this randomized study
allows evaluating the efficacy of IFSI and TFSI with a power of
80%, our sample size is small for a study design of noninferiority
comparing both interventions, to prove, without a doubt, that
IFSIs are not less effective than TFSIs in treating cervical radicu-
lopathy. This would require a prohibitively greater number of
subjects. Nevertheless, this study is one of the few randomized
controlled trials examining the efficacy of TFSI for the treatment
of cervical radiculopathy and provides specialists who treat these
patients and who perform these interventions with data to con-
sider an alternative technique.
Although including 2 different etiologic causes for radiculop-
athy could be perceived as a limitation of this study, this is more
representative of common clinical practice. According to Rad-
hakrishnan et al,2 disk herniation is responsible for cervical radic-
ulopathy in 20%–25% of cases, and spondylosis with or without
disk herniation, in 70%–75% of the cases. Furthermore, regard-
less of the current etiology of cervical radiculopathy, the inclusion
and exclusion criteria, the outcome measures, and the clinical
question that we were addressing remained the same. Finally, al-
though in our study we did not attempt to rupture the joint cap-
sule while performing IFSI, we will address the issue of the poten-
tial interaction between contrast distribution and the efficacy of
cervical corticosteroid injections in a future retrospective analysis
of our data base.
CONCLUSIONS
IFSIs are effective for the treatment of cervical radiculopathy due
to spondylosis and/or disk herniation. IFSIs were more or at least
as effective as TFSIs in providing pain relief when the baseline
pain severity score was low-to-moderate, while the comparison
between the 2 interventions remained inconclusive for severe
baseline pain level. IFSI can represent a valid and safer alternative
to TFSI because no serious complications have been reported to
date with this approach, to our knowledge. Consequently, we sug-
gest that within an optimized medical treatment management,
corticosteroid injections should initially be performed by using
an intra-articular facet approach instead of a transforaminal
approach.
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